Submitted URL: https://link.email.empr.com/a/1323/click/122433/6789979/0e18d94f8ebbc199a68ee7699911a62d1f84c68a/0c37d711f8704c6c79706e29f99...
Effective URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/...
Submission: On February 11 via manual from US

Summary

This website contacted 43 IPs in 6 countries across 32 domains to perform 175 HTTP transactions. The main IP is 34.193.226.227, located in Ashburn, United States and belongs to AMAZON-AES, US. The main domain is www.cancertherapyadvisor.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on February 5th 2020. Valid for: 2 years.
This is the only time www.cancertherapyadvisor.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.129.105 15169 (GOOGLE)
40 34.193.226.227 14618 (AMAZON-AES)
11 142.250.185.130 15169 (GOOGLE)
6 2606:4700::68... 13335 (CLOUDFLAR...)
2 65.9.69.116 16509 (AMAZON-02)
4 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:206... 16509 (AMAZON-02)
3 52.216.176.149 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2606:4700:10:... 13335 (CLOUDFLAR...)
5 2a00:1450:400... 15169 (GOOGLE)
1 54.209.3.159 14618 (AMAZON-AES)
4 52.5.164.199 14618 (AMAZON-AES)
6 2a00:1450:400... 15169 (GOOGLE)
1 5 23.218.208.121 16625 (AKAMAI-AS)
1 4 104.108.64.33 16625 (AKAMAI-AS)
2 2606:4700:20:... 13335 (CLOUDFLAR...)
1 3.211.216.130 14618 (AMAZON-AES)
1 2606:4700:303... 13335 (CLOUDFLAR...)
12 100.26.59.51 14618 (AMAZON-AES)
6 13.224.196.58 16509 (AMAZON-02)
7 2a01:111:f100... 8075 (MICROSOFT...)
1 2 54.74.23.153 16509 (AMAZON-02)
6 3.221.108.253 14618 (AMAZON-AES)
1 65.9.69.72 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
7 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
1 52.86.201.23 14618 (AMAZON-AES)
9 54.210.166.195 14618 (AMAZON-AES)
2 4 34.102.246.198 15169 (GOOGLE)
2 3 37.252.173.27 29990 (ASN-APPNEX)
1 3.233.21.95 14618 (AMAZON-AES)
1 35.175.47.233 14618 (AMAZON-AES)
2 2 54.74.225.211 16509 (AMAZON-02)
4 2606:4700:e4:... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 1 2606:4700:e4:... 13335 (CLOUDFLAR...)
1 35.160.123.46 16509 (AMAZON-02)
5 130.211.16.136 15169 (GOOGLE)
175 43
Apex Domain
Subdomains
Transfer
40 cancertherapyadvisor.com
www.cancertherapyadvisor.com
897 KB
18 deepintent.com
prebid.deepintent.com
match.deepintent.com
cdn.deepintent.com
454 B
13 googlesyndication.com
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
13 KB
12 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
265 KB
10 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
19 KB
9 clickcease.com
www.clickcease.com
monitor.clickcease.com
24 KB
8 feathr.co
cdn.feathr.co
polo.feathr.co
marco.feathr.co
polo-v1.feathr.co
37 KB
8 bibblio.org
cdn.bibblio.org
api.bibblio.org
29 KB
6 b2c.com
api.b2c.com
api-35-160-123-46.b2c.com
v4-api-35-160-123-46.b2c.com
8 KB
6 adroll.com
s.adroll.com
d.adroll.com
71 KB
6 google-analytics.com
www.google-analytics.com
53 KB
6 cookielaw.org
cdn.cookielaw.org
113 KB
5 gstatic.com
fonts.gstatic.com
71 KB
4 lhmos.com
trc.lhmos.com
823 B
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 medtargetsystem.com
www.medtargetsystem.com
79 KB
4 googleapis.com
fonts.googleapis.com
2 KB
3 adnxs.com
ib.adnxs.com
2 KB
3 google.com
www.google.com
adservice.google.com
424 B
3 amazonaws.com
s3.amazonaws.com
2 MB
2 adsrvr.org
match.adsrvr.org
955 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 googletagservices.com
www.googletagservices.com
28 KB
1 nextroll.com
nextroll.com
2 KB
1 thrtle.com
thrtle.com
1 google.be
adservice.google.be
803 B
1 google.de
www.google.de
107 B
1 consensu.org
d.adroll.mgr.consensu.org
138 B
1 tapnative.com
content.tapnative.com
229 B
1 onetrust.com
geolocation.onetrust.com
551 B
1 googletagmanager.com
www.googletagmanager.com
58 KB
1 empr.com
link.email.empr.com
920 B
175 32
Domain Requested by
40 www.cancertherapyadvisor.com www.cancertherapyadvisor.com
12 prebid.deepintent.com www.cancertherapyadvisor.com
11 securepubads.g.doubleclick.net www.cancertherapyadvisor.com
securepubads.g.doubleclick.net
9 subapi.haymarketmedia.com s3.amazonaws.com
7 7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com securepubads.g.doubleclick.net
7 monitor.clickcease.com www.clickcease.com
6 api.bibblio.org cdn.bibblio.org
6 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.cancertherapyadvisor.com
6 cdn.cookielaw.org www.cancertherapyadvisor.com
cdn.cookielaw.org
5 cdn.deepintent.com www.cancertherapyadvisor.com
5 polo.feathr.co cdn.feathr.co
www.cancertherapyadvisor.com
5 s.adroll.com 1 redirects www.googletagmanager.com
www.cancertherapyadvisor.com
s.adroll.com
5 fonts.gstatic.com fonts.googleapis.com
4 api-35-160-123-46.b2c.com 1 redirects www.cancertherapyadvisor.com
api-35-160-123-46.b2c.com
4 trc.lhmos.com 2 redirects www.cancertherapyadvisor.com
www.medtargetsystem.com
4 sb.scorecardresearch.com 1 redirects www.googletagmanager.com
www.cancertherapyadvisor.com
4 www.medtargetsystem.com www.cancertherapyadvisor.com
www.medtargetsystem.com
4 fonts.googleapis.com www.cancertherapyadvisor.com
s3.amazonaws.com
3 pagead2.googlesyndication.com securepubads.g.doubleclick.net
3 ib.adnxs.com 2 redirects www.cancertherapyadvisor.com
3 tpc.googlesyndication.com securepubads.g.doubleclick.net
tpc.googlesyndication.com
3 s3.amazonaws.com www.cancertherapyadvisor.com
2 match.adsrvr.org 2 redirects
2 www.google.com www.cancertherapyadvisor.com
tpc.googlesyndication.com
2 www.clickcease.com www.cancertherapyadvisor.com
2 cdn.bibblio.org www.cancertherapyadvisor.com
1 v4-api-35-160-123-46.b2c.com
1 api.b2c.com www.cancertherapyadvisor.com
1 polo-v1.feathr.co www.cancertherapyadvisor.com
1 www.googletagservices.com securepubads.g.doubleclick.net
1 nextroll.com www.cancertherapyadvisor.com
1 match.deepintent.com www.cancertherapyadvisor.com
1 thrtle.com www.cancertherapyadvisor.com
1 adservice.google.com securepubads.g.doubleclick.net
1 adservice.google.be securepubads.g.doubleclick.net
1 www.google.de www.cancertherapyadvisor.com
1 stats.g.doubleclick.net www.google-analytics.com
1 marco.feathr.co www.cancertherapyadvisor.com
1 d.adroll.com www.cancertherapyadvisor.com
1 d.adroll.mgr.consensu.org 1 redirects
1 cdn.feathr.co www.cancertherapyadvisor.com
1 accounts.haymarketmedia.com www.cancertherapyadvisor.com
1 mpct1.maropost.com content.maropost.com
1 content.tapnative.com www.cancertherapyadvisor.com
1 geolocation.onetrust.com cdn.cookielaw.org
1 www.googletagmanager.com www.cancertherapyadvisor.com
1 content.maropost.com www.cancertherapyadvisor.com
1 link.email.empr.com 1 redirects
175 48

This site contains no links.

Subject Issuer Validity Valid
*.cancertherapyadvisor.com
RapidSSL RSA CA 2018
2020-02-05 -
2022-03-06
2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
cookielaw.org
Cloudflare Inc ECC CA-3
2020-07-01 -
2021-07-01
a year crt.sh
cdn.bibblio.org
Amazon
2020-06-20 -
2021-07-20
a year crt.sh
upload.video.google.com
GTS CA 1O1
2021-01-26 -
2021-04-20
3 months crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2020-08-04 -
2021-08-09
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2021-01-26 -
2021-04-20
3 months crt.sh
*.onetrust.com
DigiCert SHA2 Secure Server CA
2020-05-21 -
2022-07-27
2 years crt.sh
*.gstatic.com
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
*.tapnative.com
Amazon
2020-07-31 -
2021-08-31
a year crt.sh
medtargetsystem.com
Amazon
2020-10-27 -
2021-11-26
a year crt.sh
*.adroll.com
DigiCert SHA2 Secure Server CA
2020-01-29 -
2021-04-29
a year crt.sh
sb.scorecardresearch.com
DigiCert Secure Site ECC CA-1
2020-07-17 -
2021-06-02
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2020-08-02 -
2021-08-02
a year crt.sh
accounts.haymarketmedia.com
Amazon
2020-08-30 -
2021-09-30
a year crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2020-04-09 -
2022-06-08
2 years crt.sh
api.bibblio.org
Amazon
2020-10-07 -
2021-11-07
a year crt.sh
*.clickcease.com
Go Daddy Secure Certificate Authority - G2
2019-07-29 -
2021-07-25
2 years crt.sh
adroll.mgr.consensu.org
Amazon
2020-10-08 -
2021-11-07
a year crt.sh
polo.feathr.co
R3
2020-12-25 -
2021-03-25
3 months crt.sh
marco.feathr.co
Amazon
2020-08-22 -
2021-09-22
a year crt.sh
www.google.com
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
www.google.de
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
*.google.be
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
*.google.com
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2021-01-19 -
2021-04-13
3 months crt.sh
*.thrtle.com
Go Daddy Secure Certificate Authority - G2
2020-03-22 -
2021-05-21
a year crt.sh
subapi.haymarketmedia.com
Amazon
2020-05-30 -
2021-06-30
a year crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
trc.lhmos.com
GTS CA 1D2
2021-01-14 -
2021-04-14
3 months crt.sh
nextroll.com
R3
2021-01-20 -
2021-04-20
3 months crt.sh
*.b2c.com
R3
2021-01-06 -
2021-04-06
3 months crt.sh

This page contains 15 frames:

Primary Page: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Frame ID: B0DEE6FE216719A38D3FC80D9D813A9B
Requests: 153 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F&_sid=de045129-d7c2-4c0d-88da-4a2a8664b250&_vid=13f7036f-32be-4b52-9c46-69ef9ffb9a25&_ak=35-216-F39B4873&_flash=false&_th=1613025604|1613025604|1
Frame ID: F381E74A0CC0CED1E339B0FB8C96AE26
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: B4396858B0805A07FFED57125BE110C8
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 6580CF8A10E442E1FF99BCBCA8792786
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 129385BBE432F439DAB7F63C012EE09B
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 39EF693B5D101B3E160F79B99DDD94F3
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 42B4ED0E1D64315D9BDA60C919AC6C8E
Requests: 1 HTTP requests in this frame

Frame: https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Frame ID: 98003FEA461383E27633C9F92401AA22
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/221/runner.html
Frame ID: 7E13AB7E5633F1C774FC1594087BDE65
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 58A6FD1109255F8871353DE87233D36B
Requests: 1 HTTP requests in this frame

Frame: https://cdn.deepintent.com/syncpixel.html
Frame ID: 57C027AC70CE9AB69CF83A789D05DE89
Requests: 1 HTTP requests in this frame

Frame: https://cdn.deepintent.com/syncpixel.html
Frame ID: EA077EF5E308BB80613EFEE2E89757B9
Requests: 1 HTTP requests in this frame

Frame: https://cdn.deepintent.com/syncpixel.html
Frame ID: 606EDF28A3D6A400AA3048C1E66A9B48
Requests: 1 HTTP requests in this frame

Frame: https://cdn.deepintent.com/syncpixel.html
Frame ID: EB5D4349F05399B636C9303E385DA53D
Requests: 1 HTTP requests in this frame

Frame: https://cdn.deepintent.com/syncpixel.html
Frame ID: 6EDFF063B7655142B9494D126FDEBB57
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. https://link.email.empr.com/a/1323/click/122433/6789979/0e18d94f8ebbc199a68ee7699911a62d1f84c68a/0c37d71... HTTP 302
    https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/as... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Page Statistics

175
Requests

100 %
HTTPS

45 %
IPv6

32
Domains

48
Subdomains

43
IPs

6
Countries

3430 kB
Transfer

7575 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://link.email.empr.com/a/1323/click/122433/6789979/0e18d94f8ebbc199a68ee7699911a62d1f84c68a/0c37d711f8704c6c79706e29f997221ce4155710 HTTP 302
    https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 66
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&c9=&cs_ak_ss=1
Request Chain 90
  • https://s.adroll.com/j/exp/UZ6KLH3SFFHGXARTYL3HIJ/index.js HTTP 302
  • https://s.adroll.com/j/exp/index.js
Request Chain 92
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/UZ6KLH3SFFHGXARTYL3HIJ?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2 HTTP 302
  • https://d.adroll.com/consent/check/UZ6KLH3SFFHGXARTYL3HIJ/?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2
Request Chain 136
  • https://trc.lhmos.com/enrich/data/jsonp?mid=47&mcode=15710&callback=__jp0 HTTP 302
  • https://ib.adnxs.com/getuidp?callback=__jp0
Request Chain 138
  • https://trc.lhmos.com/uid/set?dgid=UNK&mcode=15710&mid=47 HTTP 302
  • https://ib.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=$UID HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fdgid%3DUNK%26mcode%3D15710%26mid%3D47%26uid%3D%24UID HTTP 302
  • https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=4041086862038597955
Request Chain 153
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=6024d144d6e61100084752f1&gdpr=0 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=6024d144d6e61100084752f1&gdpr=0 HTTP 302
  • https://polo-v1.feathr.co/v1/analytics/match?f_id=6024d144d6e61100084752f1&ttd_id=964c2c6d-37d9-49e2-bc0c-2de7e6966a94
Request Chain 169
  • https://api-35-160-123-46.b2c.com/api/x?wg2ISyCZJgsS24mL$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~ HTTP 302
  • https://v4-api-35-160-123-46.b2c.com:444/api/4?wg2ISyCZJgsS24mL

175 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/
Redirect Chain
  • https://link.email.empr.com/a/1323/click/122433/6789979/0e18d94f8ebbc199a68ee7699911a62d1f84c68a/0c37d711f8704c6c79706e29f997221ce4155710
  • https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_...
115 KB
24 KB
Document
General
Full URL
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx / WP Engine
Resource Hash
9effc6d55e9aab90b33425ecf855f4db63eed36266f1267301039ed5e763c637
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

:method
GET
:authority
www.cancertherapyadvisor.com
:scheme
https
:path
/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

server
nginx
date
Thu, 11 Feb 2021 06:40:03 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-frame-options
SAMEORIGIN
x-distributor
yes
x-pingback
https://www.cancertherapyadvisor.com/xmlrpc.php
link
<https://www.cancertherapyadvisor.com/wp-json/>; rel="https://api.w.org/" <https://www.cancertherapyadvisor.com/wp-json/wp/v2/posts/99088>; rel="alternate"; type="application/json" <https://www.cancertherapyadvisor.com/?p=99088>; rel=shortlink
x-powered-by
WP Engine
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
MISS
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
br

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Status
302 Found
Cache-Control
no-cache
Vary
Origin
X-XSS-Protection
1; mode=block
X-Request-Id
39851f5d-ac5f-4304-9e30-0874e4b56cf3
Location
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
X-Runtime
0.032141
X-Content-Type-Options
nosniff
Date
Thu, 11 Feb 2021 06:40:01 GMT
Set-Cookie
_session_id=2e1d68be28f828fd739f495fc2bbba85; path=/; expires=Thu, 11 Feb 2021 18:40:01 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.5
Server
nginx/1.14.0 + Phusion Passenger 5.3.5
gpt.js
securepubads.g.doubleclick.net/tag/js/
56 KB
19 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
sffe /
Resource Hash
58b58226ecd10f0c003bc881de86c1bc96cbf96bf1e2d36d9836ff0cad183c7b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"780 / 808 of 1000 / last-modified: 1612998653"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19122
x-xss-protection
0
expires
Thu, 11 Feb 2021 06:40:03 GMT
prebid.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/
145 KB
46 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
981146c05d1a4ffc5cd6b799789d5c1ef65a8ef317775f16357c68867f938f7a

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Mon, 28 Sep 2020 15:18:37 GMT
server
nginx
etag
W/"5f71fecd-24405"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
otSDKStub.js
cdn.cookielaw.org/scripttemplates/
13 KB
5 KB
Script
General
Full URL
https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dd4b42f7c8ddeeedbc0e556a5da8b647fd08c56a2ac3540b1e5a6d9342ba5c4f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
XGEj0K3rTilYfgfnFZGB2g==
age
7068
vary
Accept-Encoding
content-length
4211
cf-request-id
08316a8723000018e55a1cb000000001
x-ms-lease-status
unlocked
last-modified
Thu, 28 Jan 2021 07:37:57 GMT
server
cloudflare
etag
0x8D8C35FA1761C2B
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript
access-control-allow-origin
*
x-ms-request-id
89c4d4e9-301e-0099-5a55-f55724000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=14400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc13850f7018e5-FRA
all.min.css
www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/assets/fontawesome/css/
46 KB
10 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/assets/fontawesome/css/all.min.css?ver=1584618088
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8891a160f8a2afb81de5259f9f68e5af3782348ea2927ad9e969bc88c7d39984

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 19 Mar 2020 11:41:28 GMT
server
nginx
etag
W/"5e735a68-b752"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
style.min.css
www.cancertherapyadvisor.com/wp-includes/css/dist/block-library/
53 KB
8 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-includes/css/dist/block-library/style.min.css?ver=5.5.3
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8c626f0f9b5c109539b256b73e72c02b300a184f46b4535c2eb86599215c78af

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 27 Aug 2020 18:00:38 GMT
server
nginx
etag
W/"5f47f4c6-d293"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
blocks.style.build.css
www.cancertherapyadvisor.com/wp-content/plugins/hm-custom-blocks/dist/
27 KB
5 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-custom-blocks/dist/blocks.style.build.css?ver=1607012707
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
42d42766ad0526901377a7ab2f423da2a933191f5b86001081313816ea89075d

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 03 Dec 2020 16:25:07 GMT
server
nginx
etag
W/"5fc91163-6b71"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
blocks.style.build.css
www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/
44 KB
7 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/blocks.style.build.css?ver=1601985150
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
4d48318b2dc8ed874329a8290d23794d0e53e8e185fae8ab9c91fef31c423a97

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 06 Oct 2020 11:52:30 GMT
server
nginx
etag
W/"5f7c5a7e-af72"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
shared-style.min.css
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/
49 KB
7 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1604347062
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
14ba4cf531d37fea632da4b18aad3d8578fd330b596bee85c0bb84b12ec95b70

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Mon, 02 Nov 2020 19:57:42 GMT
server
nginx
etag
W/"5fa064b6-c36b"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
bib-related-content.min.css
cdn.bibblio.org/rcm/4.9/
22 KB
4 KB
Stylesheet
General
Full URL
https://cdn.bibblio.org/rcm/4.9/bib-related-content.min.css
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.69.116 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
fa30597c8340ed18b045cc801a2dfb2e1185f9ca5ea02753e5935e64df5aa4c5

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Feb 2021 20:18:39 GMT
content-encoding
gzip
last-modified
Fri, 20 Mar 2020 10:35:36 GMT
server
AmazonS3
age
37322
etag
W/"81695cfb2a7f57aed84745a9848ba3df"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
via
1.1 7e513424eee237ee26467e8fd5656ec1.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-C1
x-amz-cf-id
_TjelN62QpkaJUKWTs2E6CKcNK_3cvoQa757wpxQHmU1lUx33CjO6g==
dashicons.min.css
www.cancertherapyadvisor.com/wp-includes/css/
58 KB
35 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-includes/css/dashicons.min.css?ver=5.5.3
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
dc1a3a3bf97eada084f65b5d87085ddb8d3a76a9e450c6a41211e1698048de91

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Fri, 17 Jul 2020 17:11:03 GMT
server
nginx
etag
W/"5f11dba7-e681"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
hm-bibblio.min.css
www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/css/
12 KB
2 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/css/hm-bibblio.min.css?ver=1.0.19
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ac4cee5f556aa6f7b5a9fb0a3dbc33cea57b735f2e0bba481a32395a45439c0e

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 12 May 2020 17:42:39 GMT
server
nginx
etag
W/"5ebae00f-3009"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
style.min.css
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/
262 KB
33 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1612974275
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3ff42134b009e0640782ef86c11884ff4bb857152f6a8e3b17970b0a1853a3e3

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 10 Feb 2021 16:24:35 GMT
server
nginx
etag
W/"602408c3-41876"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
4 KB
610 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
865d802e7d61c67356cc74aba13aa5db46011c98bf28e0350aba8d3e981eb612
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 06:36:25 GMT
server
ESF
date
Thu, 11 Feb 2021 06:40:03 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 11 Feb 2021 06:40:03 GMT
lytics.min.css
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/
41 KB
4 KB
Stylesheet
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1598539334
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e8f39acd65ceb7ad6ed97cc1e7decee74f94f2747125dacae74a8fb153751d4c

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 27 Aug 2020 14:42:14 GMT
server
nginx
etag
W/"5f47c646-a519"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
713 B
445 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=1.0.58
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
86991715857d1137866e318434c7e43873988d2abdc8e77186364bd0e53027a0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 04:59:12 GMT
server
ESF
date
Thu, 11 Feb 2021 06:40:03 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 11 Feb 2021 06:40:03 GMT
jquery.js
www.cancertherapyadvisor.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Fri, 17 May 2019 04:25:54 GMT
server
nginx
etag
W/"5cde37d2-17a69"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cookie.min.js
www.cancertherapyadvisor.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
local-storage-lib.js
www.cancertherapyadvisor.com/wp-content/plugins/browser-tag/js/
2 KB
1 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/browser-tag/js/local-storage-lib.js?ver=1.1.1
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
249bfad1337e7737c1981d1ff2441bb6bd715a04eb0d87071773c947205375dd

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 07 May 2020 20:12:08 GMT
server
nginx
etag
W/"5eb46b98-935"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
uuidv4.min.js
www.cancertherapyadvisor.com/wp-content/plugins/browser-tag/node_modules/uuid/dist/umd/
1 KB
894 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/browser-tag/node_modules/uuid/dist/umd/uuidv4.min.js?ver=1.1.1
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ab353c75467a846c7940f3458d31aff7b6ae1eb7b39e78ffa57a20dd8019c6d3

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 21 Oct 2020 18:28:46 GMT
server
nginx
etag
W/"5f907dde-550"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
deepintent.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/
23 B
243 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/deepintent.js?ver=1.1.0
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ccf38094d47cae1178221b90e94b50cb92fed8a79562c7db3ce6380b3b00250d

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Mon, 14 Dec 2020 20:33:32 GMT
server
nginx
etag
W/"5fd7cc1c-17"
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hm-npi-manager.min.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-npi-manager/dist/
213 KB
40 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-npi-manager/dist/hm-npi-manager.min.js?ver=3.0.0
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3a41e0453fbf118eb57caaddc3b894a9dc1f1573b087e44b293f81cd6f9aa684

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 07 Jan 2021 15:47:23 GMT
server
nginx
etag
W/"5ff72d0b-353a7"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hm-sponsored-content-ad-module.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-sponsored-content-ad/js/
1 KB
694 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-sponsored-content-ad/js/hm-sponsored-content-ad-module.js?ver=1.0.2
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
0ab8a835ddc4f01cd00427119dcdc7a6f198835ae7cf54f2feee63d234df5f1e

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 12 May 2020 17:42:39 GMT
server
nginx
etag
W/"5ebae00f-468"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hm-throtle-manager.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-throtle-manager/js/
512 B
463 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-throtle-manager/js/hm-throtle-manager.js?ver=1.0.1
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3e8ea32832a14443451a66dd48f30c5fef7f97c3ff4fd8ea19ef1e6c2b21694e

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 21 Oct 2020 18:28:47 GMT
server
nginx
etag
W/"5f907ddf-200"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
UtilityMove-custom.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/vendor/
2 KB
989 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1575973829
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 10 Dec 2019 10:30:29 GMT
server
nginx
etag
W/"5def73c5-751"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
polyfill.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
headerBidderDfpRevised.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/
42 KB
13 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/headerBidderDfpRevised.min.js?ver=1612974275
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
1a6f95e408dfaad5c63658e49ad30d1340ee783423ec9e3213299bd5e8376e5c

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 10 Feb 2021 16:24:35 GMT
server
nginx
etag
W/"602408c3-a8f3"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cta061115_784552.png
www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/
7 KB
7 KB
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/cta061115_784552.png
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
701254daa9cfe1258e9073c729c08c61b9552ce69cff28620c5f8052b10e600f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Thu, 11 Feb 2021 06:40:03 GMT
last-modified
Mon, 11 Mar 2019 03:33:46 GMT
server
nginx
etag
"408a20b0428372a0bd2993aa5354451e"
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=2592000
accept-ranges
bytes
content-length
6999
expires
Sat, 13 Mar 2021 06:40:03 GMT
Andrea-S.-Blevins-Primeau-PhD-MBA-150x150.jpg
www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2019/07/
7 KB
7 KB
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2019/07/Andrea-S.-Blevins-Primeau-PhD-MBA-150x150.jpg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6bc078675970fb8a134f27baea9599dd53d51fd013ca029276d1abba5e4c0dd8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Thu, 11 Feb 2021 06:40:03 GMT
last-modified
Mon, 14 Sep 2020 07:10:34 GMT
server
nginx
etag
"a0c36a6103c36a4cb5a97852f391bab1"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
content-length
7401
expires
Sat, 13 Mar 2021 06:40:03 GMT
spinner.svg
www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/inc/assets/
694 B
615 B
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/inc/assets/spinner.svg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 12 May 2020 17:42:39 GMT
server
nginx
etag
W/"5ebae00f-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
close.svg
www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src/
932 B
676 B
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src/close.svg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2dcb03eeeb1023abc76b484909142a974c9739f09cf9314b5a3d7242c3dac33b

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
etag
W/"5c99e3ee-3a4"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
spinner.svg
www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src/
694 B
615 B
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
c7fa02296c641d960c8af19fa87e00e1390a60a3-v2.js
content.maropost.com/uploads/1323/websites/2/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/2/c7fa02296c641d960c8af19fa87e00e1390a60a3-v2.js?ver=1.1
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:206f:cc00:a:1779:3180:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
fb8c8827c0cd86a31d6f0bae6f1ad899caf245a8c96c8bd0d50a55507e255f26

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 03:45:17 GMT
via
1.1 58b39782bf40f627ace295c1c6f59840.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:47:55 GMT
server
AmazonS3
age
10487
etag
"889ab51c8ff7103a4ee5328671608332"
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA56-C1
accept-ranges
bytes
content-length
2622
x-amz-cf-id
84T3wnQiH3w4FISkHPkqheE01Oe08mBHHwyK7pC-Y4vSky65VR-NWw==
hmCustomBlocks.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-custom-blocks/dist/assets/js/
113 B
311 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-custom-blocks/dist/assets/js/hmCustomBlocks.js?ver=0.0.17
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
774baa1cc429f4562336672efa73e51cd3b2c2eda5e3676eff928a3633c3b6ae

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 03 Sep 2020 19:07:26 GMT
server
nginx
etag
W/"5f513eee-71"
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
blocks.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1608135108
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a0397cb1fd493a00bef1907debf5baf92366a8d334228599cf4a98c84261f9a0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 16 Dec 2020 16:11:48 GMT
server
nginx
etag
W/"5fda31c4-1c87"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hmBibblio.min.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/js/
1 MB
262 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/js/hmBibblio.min.js?ver=1.0.19
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
96e88be5327146e869b445f19cb51260268d751ae35166eb1270823c29f60fa7

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 16 Dec 2020 16:11:48 GMT
server
nginx
etag
W/"5fda31c4-118f88"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
bib-related-content.min.js
cdn.bibblio.org/rcm/4.9/
45 KB
11 KB
Script
General
Full URL
https://cdn.bibblio.org/rcm/4.9/bib-related-content.min.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.69.116 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
5b21d495e672a89a4d8dc047b17ab94531525297644c1a4340a2bc3f26ab782f

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Feb 2021 20:17:52 GMT
content-encoding
gzip
last-modified
Fri, 20 Mar 2020 10:35:37 GMT
server
AmazonS3
age
37332
etag
W/"1274153c15863a39c136e9954d12299d"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 7e513424eee237ee26467e8fd5656ec1.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-C1
x-amz-cf-id
OOciZiWfglolmu__j-dxFgdTp8s1APuJLxaq8kX5iNGwY1fk6IdszQ==
hm-bibblio-mgr.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-manager/js/
179 B
349 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-manager/js/hm-bibblio-mgr.js?ver=1.3.7
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
34b2f1aef26290392347f17e69cd9b84e0508db56f013fba76aa6ab1abfa2045

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 03 Feb 2021 19:24:55 GMT
server
nginx
etag
W/"601af887-b3"
vary
Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
feather-tool.js
www.cancertherapyadvisor.com/wp-content/plugins/hm-feathr-tool/js/
548 B
567 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-feathr-tool/js/feather-tool.js?ver=1.2
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
579a9beff0c400b8b0e87f99d32c3ec8b2b3232232d6ac63438434a0a0d7a8b7

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 19 Sep 2019 12:23:39 GMT
server
nginx
etag
W/"5d83734b-224"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
dismiss.js
www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/assets/js/
923 B
662 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/plugins/atomic-blocks/dist/assets/js/dismiss.js?ver=1590693314
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
91690ac97c038313496895a305a808da41d7702f5568ebc6b34a4c3cdd549961

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Thu, 28 May 2020 19:15:14 GMT
server
nginx
etag
W/"5ed00dc2-39b"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
870 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?vt=15.38.9&ver=1.0.58
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.176.149 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
5e8095cad5b71456e02e88835892814dba44009f6403b5a84416db008e5d357f

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:05 GMT
Last-Modified
Tue, 11 Aug 2020 02:56:01 GMT
Server
AmazonS3
x-amz-request-id
6WDN5N8Z7ZFN4XFW
ETag
"da9d29c4843b0bac5dd6ef34da93b22e"
Content-Type
application/javascript
x-amz-version-id
lBVwAglHDmp6fLxZy4fz12pXZDZUxHyZ
Accept-Ranges
bytes
Content-Length
870
x-amz-id-2
o/aSDyG+pvwSmWPG5mkBHdmbfUg0wPqdW21dQSjNKSCAdHC0Bo+7F0+nP8180txFj9yDBQWjJCs=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
357 KB
357 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.176.149 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:05 GMT
Last-Modified
Tue, 11 Aug 2020 02:56:01 GMT
Server
AmazonS3
x-amz-request-id
4DFF87BFB8A922AB
ETag
"3d50e45eac853d7ff5898c6e8355f1cb"
Content-Type
application/javascript
x-amz-version-id
wulLLPFCPRcEdDRYL1_1QW.A2D.Je67N
Accept-Ranges
bytes
Content-Length
365126
x-amz-id-2
UAjsABcCJasKnYzaDdoLv74g3h9r4nA55HLUeiMTjuJ6BtyMqy45JPZcGog8SuFOWTTXQ0PgWRQ=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?vt=15.38.9&ver=1.0.58
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.176.149 Ashburn, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:05 GMT
Last-Modified
Tue, 11 Aug 2020 02:56:01 GMT
Server
AmazonS3
x-amz-request-id
6830849E84052715
ETag
"7f48d5418252c54a9baf9ce1a74980be"
Content-Type
application/javascript
x-amz-version-id
P5VRJucwn2qmvNWevdaMGPbAlXCLHFuw
Accept-Ranges
bytes
Content-Length
1322506
x-amz-id-2
2f4/A9N2NEtfi5fpsD3Mc432FjVPldTiSWxLAl2QYJNEub84S1RIAOFefYR0mwhcDOBGiNf5KQs=
frontend.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/
168 KB
44 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1612380295
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7626fa45f97a614c20412f126491b5f25cebb0e605615a410be2bc5504b0ed78

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 03 Feb 2021 19:24:55 GMT
server
nginx
etag
W/"601af887-29e26"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
iab.min.js
www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ba772f2235bc0d764fa19b02a84c539b65630fb0b1713e5901f99200f718b7e3

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 16 Dec 2020 16:11:48 GMT
server
nginx
etag
W/"5fda31c4-1ecb"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
wp-embed.min.js
www.cancertherapyadvisor.com/wp-includes/js/
1 KB
951 B
Script
General
Full URL
https://www.cancertherapyadvisor.com/wp-includes/js/wp-embed.min.js?ver=5.5.3
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6ebcda7a3a41ef97f0b4071160ceb1020e540fdc0f790079a5c2ef01ab654fe0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Sat, 26 Oct 2019 00:17:07 GMT
server
nginx
etag
W/"5db39083-59a"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
af18e268-0215-41f1-8176-441f0e32d89b.json
cdn.cookielaw.org/consent/af18e268-0215-41f1-8176-441f0e32d89b/
3 KB
2 KB
XHR
General
Full URL
https://cdn.cookielaw.org/consent/af18e268-0215-41f1-8176-441f0e32d89b/af18e268-0215-41f1-8176-441f0e32d89b.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d45239450095f28e51e401ecafe23e792acae7f454f07ec4cb169da8b2d11568
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
Vjve3v47fVdT2lB/t24Hag==
age
6886
vary
Accept-Encoding
content-length
1163
cf-request-id
08316a874600002fa5b79d1000000001
x-ms-lease-status
unlocked
last-modified
Wed, 16 Dec 2020 10:49:45 GMT
server
cloudflare
etag
0x8D8A1B04D82FA50
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
1114ade1-301e-0092-1e30-004f50000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=14400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc13853a9d2fa5-FRA
gtm.js
www.googletagmanager.com/
222 KB
58 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-NPWKPG6
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
56d3571cdf3f401356fe1e5c4dcf040c20b9bac7a853bce3d27c5d9e8b6909ce
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
59407
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 06:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 11 Feb 2021 06:40:03 GMT
location
geolocation.onetrust.com/cookieconsentpub/v1/geo/
197 B
551 B
Script
General
Full URL
https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6814:b844 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b25aa5eb92fee08d51add083e5c4fa22516e9d1ab61179734fbb1e27fb7f8063
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
strict-transport-security
max-age=31536000; includeSubDomains; preload
cf-ray
61fc13876cee0eab-FRA
cf-request-id
08316a889f00000eabc4830000000001
pubads_impl_2021020801.js
securepubads.g.doubleclick.net/gpt/
288 KB
101 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
sffe /
Resource Hash
2d8a5cf0e0ee804d8ffc7cffa8ba1ec6dc69f7a7e20afefc16eb947c36aab149
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 08 Feb 2021 09:37:31 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
103421
x-xss-protection
0
expires
Thu, 11 Feb 2021 06:40:03 GMT
css2
fonts.googleapis.com/
2 KB
905 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,900&display=swap
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/css/hm-bibblio.min.css?ver=1.0.19
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
3b1f810e36aca07c104391cb0a39e5b0efdd38ced57c9e35bcdc6ee94e25263e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/wp-content/plugins/hm-bibblio-consumer/dist/css/hm-bibblio.min.css?ver=1.0.19
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 06:40:03 GMT
server
ESF
date
Thu, 11 Feb 2021 06:40:03 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 11 Feb 2021 06:40:03 GMT
src.svg
www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/
36 KB
11 KB
Other
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1611178886
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
76d9975ca8531fd19abaecb970c9c6217dc1e14effdd75f6058c9b5d6d48dacf

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
last-modified
Wed, 20 Jan 2021 21:41:26 GMT
server
nginx
etag
W/"6008a386-915b"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v17/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v17/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,900&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.cancertherapyadvisor.com
Referer
https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,900&display=swap
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 08 Feb 2021 16:27:51 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Sep 2020 18:12:25 GMT
server
sffe
age
223932
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
14176
x-xss-protection
0
expires
Tue, 08 Feb 2022 16:27:51 GMT
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v17/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v17/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,900&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.cancertherapyadvisor.com
Referer
https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,900&display=swap
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 08 Feb 2021 13:34:51 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Sep 2020 18:12:59 GMT
server
sffe
age
234312
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
14044
x-xss-protection
0
expires
Tue, 08 Feb 2022 13:34:51 GMT
S6u_w4BMUTPHjxsI5wq_Gwftx9897g.woff2
fonts.gstatic.com/s/lato/v17/
14 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v17/S6u_w4BMUTPHjxsI5wq_Gwftx9897g.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
50f4eb73e4854117bf7bf9da7dc0c17740b03b5db6eb7ee6ffc20aeb35c1ea48
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.cancertherapyadvisor.com
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Wed, 10 Feb 2021 15:39:35 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Sep 2020 18:10:38 GMT
server
sffe
age
54028
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
14836
x-xss-protection
0
expires
Thu, 10 Feb 2022 15:39:35 GMT
leukemia_G_139826003-860x567.jpg
www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/02/
187 KB
188 KB
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/02/leukemia_G_139826003-860x567.jpg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
77cfea1034e768e580a16b5084c468d74f01c63ae4de34d9ea0da91f2bb2071b
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Thu, 11 Feb 2021 06:40:03 GMT
last-modified
Wed, 11 Mar 2020 07:10:41 GMT
server
nginx
etag
"5832880f53e30c13588856f41917217e"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
content-length
191941
expires
Sat, 13 Mar 2021 06:40:03 GMT
/
content.tapnative.com/tn/
0
229 B
Script
General
Full URL
https://content.tapnative.com/tn/?aid=110655&r=5397503995829476&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.209.3.159 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-209-3-159.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
x-powered-by
Express
p3p
CP='IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT'
otBannerSdk.js
cdn.cookielaw.org/scripttemplates/6.10.0/
356 KB
78 KB
Script
General
Full URL
https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7a23e0e46e16f067271bc79c92a917c13769848457d16cdf109e4dc04c687e8f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
Bh9exWOPGIwRshWljrtlEw==
age
6897369
vary
Accept-Encoding
content-length
79698
cf-request-id
08316a88e9000018e5e18c9000000001
x-ms-lease-status
unlocked
last-modified
Mon, 23 Nov 2020 02:33:28 GMT
server
cloudflare
etag
0x8D88F582961DDDE
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript
access-control-allow-origin
*
x-ms-request-id
1f098869-501e-00cd-4b85-c1bdae000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=691200
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc1387daa818e5-FRA
expires
Fri, 19 Feb 2021 06:40:03 GMT
S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
fonts.gstatic.com/s/lato/v17/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v17/S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
fe4bbdad1d6dff75cde79f8afc07f29502bd4708cb0ce5f552083c3d81ba8382
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.cancertherapyadvisor.com
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 08 Feb 2021 16:23:36 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Sep 2020 18:12:59 GMT
server
sffe
age
224187
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
14864
x-xss-protection
0
expires
Tue, 08 Feb 2022 16:23:36 GMT
doctor-patient_G_1211642905-150x150.jpg
www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/08/
5 KB
5 KB
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/08/doctor-patient_G_1211642905-150x150.jpg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
158d3987d69b788853ba0fb884ba577f32abca25bc30ab270870145bb7b1103d
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Thu, 11 Feb 2021 06:40:03 GMT
last-modified
Thu, 10 Sep 2020 07:10:35 GMT
server
nginx
etag
"abb42781b3f7cba91db8864ea94c6658"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
content-length
4884
expires
Sat, 13 Mar 2021 06:40:03 GMT
c7fa02296c641d960c8af19fa87e00e1390a60a3.js
mpct1.maropost.com/accounts/1323/websites/2/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/2/track/c7fa02296c641d960c8af19fa87e00e1390a60a3.js?contact_id=6789979&campaign_id=122433&title=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&url=https%3A%2F%2Fcancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/2/c7fa02296c641d960c8af19fa87e00e1390a60a3-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.129.105 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
105.129.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.5 / Phusion Passenger 5.3.5
Resource Hash
b24b84b8a94a40883c39541e9cc3a574b42856ee1a4d12651a51a79029881e7e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

X-Runtime
0.028727
Date
Thu, 11 Feb 2021 06:40:04 GMT
Content-Encoding
gzip
ETag
W/"5d4143bd71ee1b1f1a6f445a6305dcb6"
Server
nginx/1.14.0 + Phusion Passenger 5.3.5
X-Powered-By
Phusion Passenger 5.3.5
Vary
Accept-Encoding, Origin
Content-Type
text/javascript; charset=utf-8
Status
200 OK
X-XSS-Protection
1; mode=block
Cache-Control
max-age=0, private, must-revalidate
Transfer-Encoding
chunked
X-Content-Type-Options
nosniff
X-Request-Id
9e80bd52-afd4-4b14-b27d-1872710b4bae
beacon.js
www.medtargetsystem.com/javascript/
313 KB
79 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.5.164.199 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-5-164-199.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
8c456a75838b9f787980a2e3d06b44f0032e011c460d0c060de5ad0f8f38db61

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
gzip
last-modified
Mon, 01 Feb 2021 17:39:15 GMT
server
Apache/2.4.7 (Ubuntu)
etag
"4e366-5ba49d52676c0-gzip"
vary
X-Forwarded-Proto,Accept-Encoding
content-type
application/javascript
accept-ranges
bytes
analytics.js
www.google-analytics.com/
46 KB
18 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NPWKPG6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e441c3e2771625ba05630ab464275136a82c99650ee2145ca5aa9853bedeb01b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Fri, 23 Oct 2020 03:00:57 GMT
server
Golfe2
age
4496
date
Thu, 11 Feb 2021 05:25:07 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
18817
expires
Thu, 11 Feb 2021 07:25:07 GMT
roundtrip.js
s.adroll.com/j/
40 KB
13 KB
Script
General
Full URL
https://s.adroll.com/j/roundtrip.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NPWKPG6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.218.208.121 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-218-208-121.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
d2ac0ca5e77bcd857442c67f81703931d79b862b0018b0f1ef687616bbaddfe2

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
zclChRNr7r3m.ciaVVGpKkRvlufinDxA
Content-Encoding
gzip
ETag
"c7f615e15ad1a7e8133df2608b479f02"
x-amz-request-id
FA1520AC223C81A6
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
12676
x-amz-id-2
Fj06IyzT0RjRpfYLSTCZ7GUhTLKM69cBstT7Z8LCrTLZgjcUPhYV3QhjYfi5NM0xRxQQOazU2wI=
Last-Modified
Wed, 03 Feb 2021 19:57:50 GMT
Server
AmazonS3
Date
Thu, 11 Feb 2021 06:40:03 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NPWKPG6
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.108.64.33 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-64-33.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:03 GMT
Content-Encoding
gzip
Connection
keep-alive
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
stat.js
www.clickcease.com/monitor/
68 KB
23 KB
Script
General
Full URL
https://www.clickcease.com/monitor/stat.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::ac43:4470 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8b327691cfbc4bbfd8b8a7f6ec49d5abfd01e44e8ded46a34330cbffc6f435b5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options sameorigin

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"report_to":"cf-nel","max_age":604800}
age
743776
access-control-allow-methods
GET,POST,OPTIONS,DELETE,PUT
strict-transport-security
max-age=31536000
vary
Accept-Encoding,User-Agent
cf-request-id
08316a89650000c26dcdb56000000001
referrer-policy
no-referrer-when-downgrade
last-modified
Tue, 02 Feb 2021 16:02:47 GMT
server
cloudflare
x-frame-options
sameorigin
etag
W/"10e99-5ba5c9a00b4e5"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-max-age
1728000
report-to
{"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=oepdriN48pcgUHPHnh7VcaDPrahYNi9CKqSQvxHPnlA6d2y%2BllNyfMA8JXHfQvIl4zEhp6YQvSkSZLD2gh4vQ3KOGfhOl9PHHo1ncuFpjELdpDi4uklCbkdC5meLHcw%3D"}]}
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=2678400
access-control-allow-credentials
true
cf-ray
61fc1388ab8cc26d-FRA
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,C$
expires
Thu, 04 Mar 2021 16:03:46 GMT
cccontrack.js
www.clickcease.com/monitor/
595 B
1 KB
Script
General
Full URL
https://www.clickcease.com/monitor/cccontrack.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::ac43:4470 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
94a462c07ae019867fa5c26a248fbff6943baeab3ff1cc3f1f81cb78b6900b63
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options sameorigin

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"report_to":"cf-nel","max_age":604800}
age
286034
access-control-allow-methods
GET,POST,OPTIONS,DELETE,PUT
strict-transport-security
max-age=31536000
vary
Accept-Encoding,User-Agent
cf-request-id
08316a89650000c26daeb5a000000001
referrer-policy
no-referrer-when-downgrade
last-modified
Sun, 25 Nov 2018 12:14:23 GMT
server
cloudflare
x-frame-options
sameorigin
etag
W/"253-57b7c282287a1"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-max-age
1728000
report-to
{"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=H8WQBQ09RngJ%2BE9wjknEPH0GNp%2B4KQpx%2FlANHGc4e81yilfcry5%2FyFn%2Bo2WFCykxN4Y0WVbvrtc%2FxpmpQVqFjZMOXeAHZYbb20vwnSQ%2BoToqbjjrr8Q44SZkaaNdrHE%3D"}]}
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=2678400
access-control-allow-credentials
true
cf-ray
61fc1388ab8dc26d-FRA
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,C$
expires
Sun, 07 Mar 2021 13:10:49 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=http...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=htt...
0
528 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&c9=&cs_ak_ss=1
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.108.64.33 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-64-33.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 11 Feb 2021 06:40:04 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1613025603913&ns_c=UTF-8&c8=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&c7=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&c9=&cs_ak_ss=1
Pragma
no-cache
Date
Thu, 11 Feb 2021 06:40:04 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
en.json
cdn.cookielaw.org/consent/af18e268-0215-41f1-8176-441f0e32d89b/9e6f7f45-b087-4d3c-a0b9-4f98378e24dc/
52 KB
13 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/consent/af18e268-0215-41f1-8176-441f0e32d89b/9e6f7f45-b087-4d3c-a0b9-4f98378e24dc/en.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
6a859612efcd702187bf6720160d84ba8e2a970a98d702d808b0971afbb01f3c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
8g9H7bDRaxSXKMfwczt9qw==
age
6885
vary
Accept-Encoding
content-length
13054
cf-request-id
08316a895c00002fa5ea31a000000001
x-ms-lease-status
unlocked
last-modified
Wed, 16 Dec 2020 10:49:50 GMT
server
cloudflare
etag
0x8D8A1B04FEEC527
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
bcda1f15-801e-0080-1ce3-d37b4c000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=14400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc13889e1d2fa5-FRA
/
accounts.haymarketmedia.com/sso/check/
45 B
624 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1612380295
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.211.216.130 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-211-216-130.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
private
access-control-allow-credentials
true
content-length
45
boomerang.min.js
cdn.feathr.co/js/
114 KB
34 KB
Script
General
Full URL
https://cdn.feathr.co/js/boomerang.min.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-feathr-tool/js/feather-tool.js?ver=1.2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3031::ac43:80a4 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
806c9975656fb05571e902f1154303c7b1553ae12444ca54da5b1a150007146c

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
br
cf-cache-status
HIT
nel
{"max_age":604800,"report_to":"cf-nel"}
age
2744
x-amz-request-id
D314B7F243CF451A
x-amz-id-2
z3WnY3e1BUu2eLeITsE5O7qhiNU86j5aGVmCVlE9p97lu7PlRV8hpoOmKeiOUxRElozO13H6+h4=
last-modified
Wed, 06 May 2020 17:47:20 GMT
server
cloudflare
etag
W/"360b036656090b581ae5d1ecb2572847"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=tk0NNZC%2Bl0eP8k4NF%2F26FMWfeADVgAOQnDobk8iXqu%2FqhMeR8LJTHdXh77xpDIfkSj2zdWUJHcUW6eA%2BYE6eHYMZv3u9sdl7ryHNTJE24JJKnjTyTfDXPPzw"}]}
content-type
application/javascript
cache-control
max-age=14400
cf-request-id
08316a89c100002bf6eb38e000000001
cf-ray
61fc138939782bf6-FRA
prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:03 GMT
server
b
prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:03 GMT
server
b
prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:03 GMT
server
b
prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
prebid
prebid.deepintent.com/
0
240 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
prebid
prebid.deepintent.com/
0
18 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
prebid
prebid.deepintent.com/
0
18 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
prebid
prebid.deepintent.com/
0
18 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:27:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
age
725
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=3600
cross-origin-resource-policy
cross-origin
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
859
x-xss-protection
0
expires
Thu, 11 Feb 2021 07:27:59 GMT
js
www.google-analytics.com/gtm/
83 KB
33 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-P4H4D95&t=gtm5&cid=1762312596.1613025604
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
1f4f91daf5cdcd2843d3e7602356ea0cbac20b6a3f4c9d38c7b2bb07817c06fa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
33505
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 06:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Thu, 11 Feb 2021 06:40:04 GMT
recommendations
api.bibblio.org/v1/ Frame
0
0
Other
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=6&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=courses
Protocol
H2
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
authorization,content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

content-type
application/json
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
x-amzn-requestid
b6fd6151-3204-4e8a-8a9b-fef5d38e54a4
access-control-allow-origin
*
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token
x-amz-apigw-id
akWiqEyQDoEF_ZQ=
access-control-allow-methods
GET,OPTIONS
x-cache
Miss from cloudfront
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
yikZGuknMS2LItA-a7Qzc38KO2ayR75tvXTxALdWLlgQqU4hrdOJhg==
recommendations
api.bibblio.org/v1/ Frame
0
0
Other
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=6&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=articles
Protocol
H2
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
authorization,content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

content-type
application/json
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
x-amzn-requestid
24317140-784d-4a55-a53f-5ec6f3653aa1
access-control-allow-origin
*
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token
x-amz-apigw-id
akWirFhMjoEF7fg=
access-control-allow-methods
GET,OPTIONS
x-cache
Miss from cloudfront
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
vzYgemXSuDFP4-d4SUmTxKyzWvTtxe3d9nKPyLdhRF8wsVgbiyGmiw==
recommendations
api.bibblio.org/v1/
5 KB
5 KB
XHR
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=6&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=courses
Requested by
Host: cdn.bibblio.org
URL: https://cdn.bibblio.org/rcm/4.9/bib-related-content.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Authorization
Bearer c61ee73c-fcfd-4d45-acdb-93a6b09284f3
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
73a9465d-8cb2-4d83-8651-1371b9ba7373
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-6024d144-015363f9230345302862856e;Sampled=0
x-amz-apigw-id
akWirFjaDoEF36g=
content-length
4908
x-amz-cf-id
QTIBWIs96MfAsTclBZU0sO8Umyfq7ogpFNk6gZTR8gp5L6Wx7tNA-A==
recommendations
api.bibblio.org/v1/
4 KB
5 KB
XHR
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=6&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=articles
Requested by
Host: cdn.bibblio.org
URL: https://cdn.bibblio.org/rcm/4.9/bib-related-content.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Authorization
Bearer c61ee73c-fcfd-4d45-acdb-93a6b09284f3
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
8b39c9ae-b623-43fa-aa69-70d8fbc32901
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-6024d144-0a45564d682191b075667921;Sampled=0
x-amz-apigw-id
akWitEyNjoEFTDg=
content-length
4356
x-amz-cf-id
OYaqIKvYzxYuOBCil3hJKasDRJZ6T_07MBztBFFRUhuNhG80QAam0Q==
recommendations
api.bibblio.org/v1/ Frame
0
0
Other
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=7&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=articles
Protocol
H2
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
authorization,content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

content-type
application/json
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
x-amzn-requestid
db5cb5fd-53bc-43e0-8951-b901a8f5d6b8
access-control-allow-origin
*
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key,X-Amz-Security-Token
x-amz-apigw-id
akWiqEBIDoEFaNg=
access-control-allow-methods
GET,OPTIONS
x-cache
Miss from cloudfront
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
KPDcRCnIULJh1WBFurBWxTBeMnLnDGD2KyIOn08QosJ4VYtL4eRxGQ==
recommendations
api.bibblio.org/v1/
5 KB
5 KB
XHR
General
Full URL
https://api.bibblio.org/v1/recommendations?limit=7&page=1&fields=name,url,moduleImage,datePublished,author,description&customUniqueIdentifier=99088&customCatalogueIds=articles
Requested by
Host: cdn.bibblio.org
URL: https://cdn.bibblio.org/rcm/4.9/bib-related-content.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.196.58 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-196-58.fra2.r.cloudfront.net
Software
/
Resource Hash

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Authorization
Bearer c61ee73c-fcfd-4d45-acdb-93a6b09284f3
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 5076c8187f430eebe5e26fc594d6125a.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
0675bafa-0f07-4f34-92a3-e257b03f69be
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-6024d144-3b7fe61e0980e9ff7ceb7f67;Sampled=0
x-amz-apigw-id
akWirH8LjoEFoww=
content-length
4994
x-amz-cf-id
kEqS-XOwr0i_YDpjoz1ZS-ZxOyxllL0PL9ALJR_pvJZq-KeXNOm-Qg==
otFlat.json
cdn.cookielaw.org/scripttemplates/6.10.0/assets/
13 KB
4 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/scripttemplates/6.10.0/assets/otFlat.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8cdca3b36914e8a3f56390da71389944579faaae82704e53bd66f9c0387502f6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
W9e0YobmEbvdB0V9OmpQkw==
age
4067906
vary
Accept-Encoding
content-length
3329
cf-request-id
08316a8a1300002fa5b483f000000001
x-ms-lease-status
unlocked
last-modified
Thu, 03 Dec 2020 02:42:50 GMT
server
cloudflare
etag
0x8D89735209A34D6
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/json
access-control-allow-origin
*
x-ms-request-id
f0a765b4-d01e-0172-0341-dbef8d000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=691200
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc1389bf452fa5-FRA
expires
Fri, 19 Feb 2021 06:40:04 GMT
otPcCenter.json
cdn.cookielaw.org/scripttemplates/6.10.0/assets/v2/
46 KB
11 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/scripttemplates/6.10.0/assets/v2/otPcCenter.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/6.10.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:9540 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3b27f686e9c39188ff63e191cc3efb6500a6c6d06f2d1d2ec27ceb623a2ecacc
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
ydfMbMpHX/N/aS5YhkXXwQ==
age
4122204
vary
Accept-Encoding
content-length
11336
cf-request-id
08316a8a1300002fa5a9279000000001
x-ms-lease-status
unlocked
last-modified
Thu, 03 Dec 2020 02:42:53 GMT
server
cloudflare
etag
0x8D89735220FDD9F
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/json
access-control-allow-origin
*
x-ms-request-id
db5696ed-001e-0030-32c2-da82cc000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=691200
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
61fc1389bf472fa5-FRA
expires
Fri, 19 Feb 2021 06:40:04 GMT
TrackConversion
monitor.clickcease.com/conversions/api/
0
26 B
XHR
General
Full URL
https://monitor.clickcease.com/conversions/api/TrackConversion
Requested by
Host: www.clickcease.com
URL: https://www.clickcease.com/monitor/cccontrack.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Microsoft-IIS/10.0 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json;charset=UTF-8

Response headers

access-control-allow-origin
*
pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
cache-control
no-cache
server
Microsoft-IIS/10.0
vm
10.1.0.24
expires
-1
TrackConversion
monitor.clickcease.com/conversions/api/ Frame
0
0
Other
General
Full URL
https://monitor.clickcease.com/conversions/api/TrackConversion
Protocol
H2
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Microsoft-IIS/10.0 /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache
pragma
no-cache
expires
-1
server
Microsoft-IIS/10.0
access-control-allow-origin
*
access-control-allow-headers
content-type
vm
10.1.0.24
date
Thu, 11 Feb 2021 06:40:04 GMT
content-length
0
index.js
s.adroll.com/j/exp/
Redirect Chain
  • https://s.adroll.com/j/exp/UZ6KLH3SFFHGXARTYL3HIJ/index.js
  • https://s.adroll.com/j/exp/index.js
28 B
747 B
Script
General
Full URL
https://s.adroll.com/j/exp/index.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.218.208.121 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-218-208-121.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
8C_4p5S6NLuKOM2fXKpm7asomxwPn3IL
Content-Encoding
gzip
ETag
"5816cced8568d223aa09d889f300692b"
x-amz-request-id
A6E4D842C4F3666B
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
48
x-amz-id-2
1Pslf+Y9QwUHIZmwUo95w2CKA8MTrgZpbGBRFLUwAevxRDJ3euWTGuAJ2AJ78njOjdUd48ZsKSg=
Last-Modified
Tue, 19 Jan 2021 16:25:36 GMT
Server
AmazonS3
Date
Thu, 11 Feb 2021 06:40:04 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*

Redirect headers

Date
Thu, 11 Feb 2021 06:40:04 GMT
Server
AkamaiGHost
Location
https://s.adroll.com/j/exp/index.js
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
false
Connection
keep-alive
Access-Control-Allow-Headers
*
Content-Length
0
index.js
s.adroll.com/j/pre/UZ6KLH3SFFHGXARTYL3HIJ/VFUE7SHRNVHQLIXICLVR2X/
1 KB
1 KB
Script
General
Full URL
https://s.adroll.com/j/pre/UZ6KLH3SFFHGXARTYL3HIJ/VFUE7SHRNVHQLIXICLVR2X/index.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.218.208.121 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-218-208-121.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
cbce85e96b7752208ce15a09ea4d5a58b792edc9e77f1c5ccf46c01935970f9d

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
553.v06l_gX_Vyo80sp6aqadEisXIiYG
Content-Encoding
gzip
ETag
"3996d65282dd996ee0d7d4c90c139158"
x-amz-request-id
21A1D80F5BB975BC
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
635
x-amz-id-2
jxwI/jB+uk8WPOjMUQAcKmiELd1zIKXAiwoGpnYfQ6HteospwT+FDMisGBRuRS9q/b05XSlShxw=
Last-Modified
Wed, 10 Feb 2021 19:52:30 GMT
Server
AmazonS3
Date
Thu, 11 Feb 2021 06:40:04 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
text/javascript; charset=utf-8
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
/
d.adroll.com/consent/check/UZ6KLH3SFFHGXARTYL3HIJ/
Redirect Chain
  • https://d.adroll.mgr.consensu.org/consent/iabcheck/UZ6KLH3SFFHGXARTYL3HIJ?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2
  • https://d.adroll.com/consent/check/UZ6KLH3SFFHGXARTYL3HIJ/?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2
385 B
477 B
Script
General
Full URL
https://d.adroll.com/consent/check/UZ6KLH3SFFHGXARTYL3HIJ/?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.74.23.153 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-74-23-153.eu-west-1.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
nginx/1.18.0
content-length
385
content-type
application/javascript

Redirect headers

location
https://d.adroll.com/consent/check/UZ6KLH3SFFHGXARTYL3HIJ/?_s=258cf2bacc5f844d60f089f09df6b8eb&_b=2
date
Thu, 11 Feb 2021 06:40:04 GMT
server
nginx/1.18.0
content-length
105
S6u9w4BMUTPHh50XSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v17/
13 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v17/S6u9w4BMUTPHh50XSwiPGQ3q5d0.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
973ebbead06df6ace22a88d2856663d37845792bdf1b40ff69df2e20912fedef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Origin
https://www.cancertherapyadvisor.com
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i,900,900i
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Mon, 08 Feb 2021 16:20:29 GMT
x-content-type-options
nosniff
last-modified
Tue, 15 Sep 2020 18:10:30 GMT
server
sffe
age
224375
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13732
x-xss-protection
0
expires
Tue, 08 Feb 2022 16:20:29 GMT
integrations
polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/
42 B
374 B
XHR
General
Full URL
https://polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/integrations
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
application/json
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
42
refresh
marco.feathr.co/v1/
43 B
585 B
Image
General
Full URL
https://marco.feathr.co/v1/refresh
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.69.72 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 106758604a7f1ae0fa6678cd3d828d62.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56-C1
x-amzn-requestid
46217dc5-bb89-439c-98ea-17ce7df19fcf
access-control-allow-methods
*
content-type
image/gif
access-control-allow-origin
*
x-amzn-trace-id
Root=1-6024d144-45b9d27230520b5f686620eb;Sampled=0
x-cache
Miss from cloudfront
x-amz-apigw-id
akWivG0WoAMFn_Q=
content-length
43
x-amz-cf-id
Gwxg4Tmx5TI-2d0pCVY4MFdeUbxya3-SrjzJbNubzIH16Asp98GGKw==
access-control-allow-headers
Content-Type,X-Amz-Date,Authorization,X-Api-Key
collect
www.google-analytics.com/j/
2 B
52 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j87&a=639314249&t=pageview&_s=1&dl=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&ul=en-us&de=UTF-8&dt=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aGDAAAAjQAAAAC~&jid=70655469&gjid=1999585220&cid=1762312596.1613025604&tid=UA-1290429-34&_gid=1808787875.1613025604&_r=1&gtm=2wg230NPWKPG6&cd1=99088%3A0&cd2=ash%202020%2Cash%202020%20cll%20in-depth%2Cchronic%20lymphocytic%20leukemia%2Chematologic%20cancers%2Cleukemia&cd3=&cd4=63&cd5=post&cd6=&cd7=home&cd8=news&cd9=conference%20coverage&cd10=american%20society%20of%20hematology%20(ash)&cd11=omn&cd12=18&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Andrea%20S.%20Blevins%20Primeau%2C%20PhD%2C%20MBA&cd35=News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd44=post%3Anone&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=12&cd57=&cd58=&cd61=false&cd62=2020-12-11&cd63=441&cd65=No&cd66=&cd67=undef&cd70=false&cd91=false&cd92=false&cd93=false&cd94=ash%202020%20cll%20in-depth&cd95=Central%20European%20Standard%20Time&cd97=&cd98=bf51f8b0f0cc63028fc738abd85858cdf5b7b4e2d296fe04c9f740089976c754&z=848500295
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
statsV2
monitor.clickcease.com/monitor/api/
42 B
105 B
XHR
General
Full URL
https://monitor.clickcease.com/monitor/api/statsV2?type=object
Requested by
Host: www.clickcease.com
URL: https://www.clickcease.com/monitor/stat.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Microsoft-IIS/10.0 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
server
Microsoft-IIS/10.0
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
no-cache
vm
10.1.0.24
content-length
42
expires
-1
collect
stats.g.doubleclick.net/j/
4 B
97 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j87&tid=UA-1290429-34&cid=1762312596.1613025604&jid=70655469&gjid=1999585220&_gid=1808787875.1613025604&_u=aGDAAAAiQAAAAC~&z=1445522762
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c04::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Thu, 11 Feb 2021 06:40:04 GMT
content-type
text/plain
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
www.medtargetsystem.com/beacon/portal/ Frame F381
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F&_sid=de045129-d7c2-4c0d-88da-4a2a8664b250&_vid=13f7036f-32be-4b52-9c46-69ef9ffb9a25&_ak=35-216-F39B4873&_flash=false&_th=1613025604|1613025604|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.5.164.199 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-5-164-199.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

:method
GET
:authority
www.medtargetsystem.com
:scheme
https
:path
/beacon/portal/?_url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F&_sid=de045129-d7c2-4c0d-88da-4a2a8664b250&_vid=13f7036f-32be-4b52-9c46-69ef9ffb9a25&_ak=35-216-F39B4873&_flash=false&_th=1613025604|1613025604|1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
content-type
text/html; charset=UTF-8
content-length
3996
server
Apache/2.4.7 (Ubuntu)
vary
X-Forwarded-Proto,Accept-Encoding
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
set-cookie
s-DMDSESSID=eshpelkq2alc78199p05fdd7j5; path=/; HttpOnly; SameSite=None; Secure; domain=www.medtargetsystem.com s-dmd-id-x=read; path=/; domain=www.medtargetsystem.com; SameSite=None; Secure
expires
Thu, 19 Nov 1981 08:52:00 GMT
cache-control
no-store, no-cache, must-revalidate
pragma
no-cache
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
content-encoding
gzip
collect.gif
www.medtargetsystem.com/analytics/
0
331 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=13f7036f-32be-4b52-9c46-69ef9ffb9a25&sid=de045129-d7c2-4c0d-88da-4a2a8664b250&vh=1&vt=1613025604&pt=1613025604&u=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&r=&t=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&p=4073.71&pm=&ab=&ak=35-216-F39B4873
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.5.164.199 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-5-164-199.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
cache-control
max-age=0, no-cache, no-store
expires
0
ga-audiences
www.google.com/ads/
42 B
107 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j87&tid=UA-1290429-34&cid=1762312596.1613025604&jid=70655469&_u=aGDAAAAiQAAAAC~&z=533736061
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
107 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j87&tid=UA-1290429-34&cid=1762312596.1613025604&jid=70655469&_u=aGDAAAAiQAAAAC~&z=533736061
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
prebid
prebid.deepintent.com/
0
18 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
integrator.js
adservice.google.be/adsid/
109 B
803 B
Script
General
Full URL
https://adservice.google.be/adsid/integrator.js?domain=www.cancertherapyadvisor.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
317 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.cancertherapyadvisor.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
104
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
101 KB
29 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=2432538167627693&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cleaderboard_top&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=728x90&prev_scp=pos%3Dleaderboard_top%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025604&dt=1613025604694&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=219&adys=102&adks=1691014614&ucis=1&ifi=1&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=942x-1&msz=942x-1&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=516&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/804849454000224509/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/804849454000224509/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPmhvNGc4e4CFZfudwodAwwK3A&gqi=&layout=/sadbundle/%24csp%253Der3%24/804849454000224509/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/804849454000224509/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/804849454000224509/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPmhvNGc4e4CFZfudwodAwwK3A&gqi=&layout=/sadbundle/%24csp%253Der3%24/804849454000224509/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28962
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Thu, 11 Feb 2021 06:40:05 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

prebid
prebid.deepintent.com/ Frame
0
0
Other
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.cancertherapyadvisor.com
vary
Origin,Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
prebid
prebid.deepintent.com/
0
18 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
100.26.59.51 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-100-26-59-51.compute-1.amazonaws.com
Software
b /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
server
b
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.cancertherapyadvisor.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
ads
securepubads.g.doubleclick.net/gampad/
85 KB
28 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=2432538167627693&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cbox_2&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=300x250%7C300x600%7C160x600%7C300x105&prev_scp=pos%3Dbox_2%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025604&dt=1613025604708&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=1060&adys=666&adks=2689864633&ucis=2&ifi=2&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x278&msz=300x250&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/10909004245542172740/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/10909004245542172740/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPHL0tGc4e4CFSyFgwcdHyYL_Q&gqi=&layout=/sadbundle/%24csp%253Der3%24/10909004245542172740/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/10909004245542172740/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/10909004245542172740/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPHL0tGc4e4CFSyFgwcdHyYL_Q&gqi=&layout=/sadbundle/%24csp%253Der3%24/10909004245542172740/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27203
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Thu, 11 Feb 2021 06:40:05 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
68 KB
15 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=2432538167627693&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cbox_1&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=300x250%7C300x600%7C160x600&prev_scp=pos%3Dbox_1%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025604&dt=1613025604716&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=1060&adys=282&adks=2925883893&ucis=3&ifi=3&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15425
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
83 KB
27 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=2432538167627693&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cbox_3&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=300x250%7C300x600%7C160x600&prev_scp=pos%3Dbox_3%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025604&dt=1613025604730&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=1060&adys=1194&adks=3176315662&ucis=4&ifi=4&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x278&msz=300x250&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/7560652060233029528/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/7560652060233029528/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CO-59tGc4e4CFRuDgwcdmhsDWQ&gqi=&layout=/sadbundle/%24csp%253Der3%24/7560652060233029528/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/7560652060233029528/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/7560652060233029528/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CO-59tGc4e4CFRuDgwcdmhsDWQ&gqi=&layout=/sadbundle/%24csp%253Der3%24/7560652060233029528/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
26772
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Thu, 11 Feb 2021 06:40:05 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
consent_tcfv2.js
s.adroll.com/j/
397 KB
55 KB
Script
General
Full URL
https://s.adroll.com/j/consent_tcfv2.js
Requested by
Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.218.208.121 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-218-208-121.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id
7sDcLvGKTPrh8xIq2f5DynXc_Mi9vQVX
Content-Encoding
gzip
ETag
"1f2c64002f8e1b6eb56c304c2e892afb"
x-amz-request-id
9C0A466D5B644741
x-amz-server-side-encryption
AES256
Connection
keep-alive
Vary
Accept-Encoding
Content-Length
55575
x-amz-id-2
RKvpIdckCIUfU1lGu4A9Vc4434+rKFeY6PhXnAc0s4O7wCj+IxmfMnCnJnqRhSwxJEODB4ztDYM=
Last-Modified
Mon, 07 Dec 2020 23:59:35 GMT
Server
AmazonS3
Date
Thu, 11 Feb 2021 06:40:04 GMT
Access-Control-Max-Age
600
Access-Control-Allow-Methods
GET
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=300, must-revalidate
Access-Control-Allow-Credentials
false
Accept-Ranges
bytes
Access-Control-Allow-Headers
*
ads
securepubads.g.doubleclick.net/gampad/
562 B
807 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=3307816912793944&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Csponsored_content&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dsponsored_content&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025604&dt=1613025604846&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=216&adys=1054&adks=3450357865&ucis=5&ifi=5&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=820x81&msz=820x0&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
308
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
insync
thrtle.com/
0
0
Script
General
Full URL
https://thrtle.com/insync?vxii_pid=30004&loc=CTA
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-throtle-manager/js/hm-throtle-manager.js?ver=1.0.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.86.201.23 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-86-201-23.compute-1.amazonaws.com
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

css
fonts.googleapis.com/
1 KB
470 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?vt=15.38.9&ver=1.0.58
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Thu, 11 Feb 2021 04:43:51 GMT
server
ESF
date
Thu, 11 Feb 2021 06:40:04 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Thu, 11 Feb 2021 06:40:04 GMT
18
subapi.haymarketmedia.com/newsletterasset/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletterasset/18
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"8d1-HTWpp+42PSQuiA1jYFx4Y8OgyRc"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
2257
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/gif
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/png
18
subapi.haymarketmedia.com/newsletter/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/18
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"8d1-HTWpp+42PSQuiA1jYFx4Y8OgyRc"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
2257
18
subapi.haymarketmedia.com/newsletter/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/18
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"8d1-HTWpp+42PSQuiA1jYFx4Y8OgyRc"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
2257
18
subapi.haymarketmedia.com/newsletter/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/18
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"8d1-HTWpp+42PSQuiA1jYFx4Y8OgyRc"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
2257
18
subapi.haymarketmedia.com/newsletter/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/18
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"8d1-HTWpp+42PSQuiA1jYFx4Y8OgyRc"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
2257
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml
collect.gif
www.medtargetsystem.com/analytics/
0
238 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=13f7036f-32be-4b52-9c46-69ef9ffb9a25&sid=de045129-d7c2-4c0d-88da-4a2a8664b250&vh=1&vt=1613025604&pt=1613025604&u=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&r=&t=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&p=4324.26&pm=&ab=&ak=35-216-F39B4873
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.5.164.199 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-5-164-199.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
server
Apache/2.4.7 (Ubuntu)
x-powered-by
PHP/7.0.19-1+deb.sury.org~trusty+2
vary
X-Forwarded-Proto
p3p
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
cache-control
max-age=0, no-cache, no-store
expires
0
entry2
monitor.clickcease.com/V2/recorder/ Frame
0
0
Other
General
Full URL
https://monitor.clickcease.com/V2/recorder/entry2
Protocol
H2
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Kestrel /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

server
Kestrel
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
*
vm
10.1.0.24
date
Thu, 11 Feb 2021 06:40:04 GMT
entry2
monitor.clickcease.com/V2/recorder/
120 B
208 B
Fetch
General
Full URL
https://monitor.clickcease.com/V2/recorder/entry2
Requested by
Host: www.clickcease.com
URL: https://www.clickcease.com/monitor/stat.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=2592000

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

access-control-allow-origin
*
strict-transport-security
max-age=2592000
server
Kestrel
vm
10.1.0.24
date
Thu, 11 Feb 2021 06:40:05 GMT
content-type
text/plain; charset=utf-8
CTA_400x300.jpg
www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/05/
56 KB
56 KB
Image
General
Full URL
https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2020/05/CTA_400x300.jpg
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
34.193.226.227 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-193-226-227.compute-1.amazonaws.com
Software
nginx /
Resource Hash
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Thu, 11 Feb 2021 06:40:05 GMT
last-modified
Sun, 07 Jun 2020 07:10:33 GMT
server
nginx
etag
"8f04572926bada7d20156c1317e5cfed"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=2592000
accept-ranges
bytes
content-length
57501
expires
Sat, 13 Mar 2021 06:40:05 GMT
ads
securepubads.g.doubleclick.net/gampad/
86 KB
28 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=3307816912793944&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cbox_bonus1&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=300x250%7C300x600%7C160x600&prev_scp=pos%3Dbox_bonus1%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025605&dt=1613025605033&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=1060&adys=2345&adks=2696151242&ucis=6&ifi=6&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x278&msz=300x250&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
Content-Security-Policy child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/8577173934072374316/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/8577173934072374316/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPaH0dGc4e4CFRkQiwod7foO_w&gqi=&layout=/sadbundle/%24csp%253Der3%24/8577173934072374316/index.html
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

content-security-policy
child-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/8577173934072374316/index.html;frame-src 'unsafe-inline' cm.g.doubleclick.net googleads.g.doubleclick.net www.google.com accounts.google.com pagead2.googlesyndication.com/pagead/s/cookie_push.html gmsg: https://tpc.googlesyndication.com/sadbundle/$csp%3Der3$/8577173934072374316/index.html;report-uri https://pagead2.googlesyndication.com/pagead/gen_csp?id=adbundle&qqi=CPaH0dGc4e4CFRkQiwod7foO_w&gqi=&layout=/sadbundle/%24csp%253Der3%24/8577173934072374316/index.html
content-encoding
br
x-content-type-options
nosniff
google-creative-id
-1
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
28239
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
date
Thu, 11 Feb 2021 06:40:05 GMT
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
57 KB
16 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=3307816912793944&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2Cin_article&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=300x250&prev_scp=pos%3Din_article%26amid%3D%26atype%3DNews%26author%3DStephan_Cho%26block%3DCTA_Verzenio_2020%2CGSK_2020%2CHMN_Alimta_2020%2CHMN_Cyramza_2020%2CHMN_Jynarque_2020%2CHMN_Rexulti_2020%2CHMN_Xyrem_2019%26browser%3DChrome%252083%26cat%3DASH_2020%2CASH_2020_CLL_In-depth%2CChronic_Lymphocytic_Leukemia%2CHematologic_Cancers%2CLeukemia%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26log%3D0%26pagetype%3Dpost%26postID%3D99088%26sid%3DASH_2020_CLL_In-depth%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie_enabled=1&bc=31&abxe=1&lmt=1613025605&dt=1613025605044&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=216&adys=1088&adks=1085147668&ucis=7&ifi=7&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=820x1972&msz=820x266&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16224
x-xss-protection
0
google-lineitem-id
-1
pragma
no-cache
server
cafe
google-creative-id
-1
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
www.google-analytics.com/
35 B
63 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j87&a=639314249&t=event&ni=0&_s=1&dl=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&ul=en-us&de=UTF-8&dt=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&ec=Restriction_Metered&ea=Static_1-5&el=n%2Fa&_u=aGDAAAAjQAAAAC~&jid=&gjid=&cid=1762312596.1613025604&tid=UA-1290429-34&_gid=1808787875.1613025604&gtm=2wg230NPWKPG6&z=724857591
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 10 Feb 2021 18:22:37 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
44248
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
533 B
560 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=3307816912793944&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2COOP_skin&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=1x1&ists=1&prev_scp=pos%3DOOP_skin%26lid%3Dnull&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie=ID%3D143269608b89c136-22ee6ce971ba0003%3AT%3D1613025604%3AS%3DALNI_MZLO7ZvTv_dpQlfT6xqDJMKpztk7g&bc=31&abxe=1&lmt=1613025605&dt=1613025605073&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3957&adks=2711189019&ucis=8&ifi=8&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x3958&msz=1600x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=2
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
291
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
ads
securepubads.g.doubleclick.net/gampad/
539 B
558 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1978444505611150&correlator=3307816912793944&output=ldjh&impl=fif&eid=21068773%2C21068891&vrg=2021020801&ptt=17&guci=1.2.0.0.2.2.0.0&sc=1&sfv=1-0-37&ecs=20210211&iu_parts=5745%2Ccta_us%2Chome%2Cnews%2Cconference-coverage%2Camerican-society-of-hematology-ash%2Cash-2020%2Cash-2020-cll-in-depth%2COOP_prestitial&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2F5%2F6%2F7%2F8&prev_iu_szs=1x1&ists=1&prev_scp=pos%3DOOP_prestitial%26lid%3Dnull&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DStephan_Cho%26postID%3D99088%26env%3Dlive%26sid%3DASH_2020_CLL_In-depth%26styleid%3D%26cat%3DASH_2020%252CASH_2020_CLL_In-depth%252CChronic_Lymphocytic_Leukemia%252CHematologic_Cancers%252CLeukemia%26atype%3DNews%26block%3DCTA_Verzenio_2020%252CGSK_2020%252CHMN_Alimta_2020%252CHMN_Cyramza_2020%252CHMN_Jynarque_2020%252CHMN_Rexulti_2020%252CHMN_Xyrem_2019%26isnht%3Dfalse%26browser%3DChrome%252083%26log%3D0%26amid%3D%26spr%3D%26ssp%3D&cookie=ID%3D143269608b89c136-22ee6ce971ba0003%3AT%3D1613025604%3AS%3DALNI_MZLO7ZvTv_dpQlfT6xqDJMKpztk7g&bc=31&abxe=1&lmt=1613025605&dt=1613025605079&dlt=1613025603340&idt=625&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3958&adks=107127981&ucis=9&ifi=9&u_tz=60&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x3959&msz=1600x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1762312596.1613025604&ga_sid=1613025605&ga_hid=639314249&fws=4&ohw=1600&btvi=3
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
297
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
getuidp
ib.adnxs.com/
Redirect Chain
  • https://trc.lhmos.com/enrich/data/jsonp?mid=47&mcode=15710&callback=__jp0
  • https://ib.adnxs.com/getuidp?callback=__jp0
18 B
693 B
Script
General
Full URL
https://ib.adnxs.com/getuidp?callback=__jp0
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.27 , Ascension Island, ASN29990 (ASN-APPNEX, US),
Reverse DNS
539.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 11 Feb 2021 06:40:05 GMT
X-Proxy-Origin
82.102.19.136; 82.102.19.136; 539.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.172.81:80
AN-X-Request-Uuid
3c612905-25d6-4b73-9b9d-b861d4214e6a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
18
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT

Redirect headers

date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 google
x-content-type-options
nosniff
alt-svc
clear
content-length
0
x-xss-protection
1; mode=block
pragma
no-cache
location
https://ib.adnxs.com/getuidp?callback=__jp0
x-frame-options
DENY
access-control-max-age
3600
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-language
en-US
access-control-allow-origin
*
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-headers
x-requested-with
expires
0
store
match.deepintent.com/usersync/114/
0
124 B
Image
General
Full URL
https://match.deepintent.com/usersync/114/store?ext1=de045129-d7c2-4c0d-88da-4a2a8664b250&id=UNK
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
3.233.21.95 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-233-21-95.compute-1.amazonaws.com
Software
envoy /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:04 GMT
x-envoy-upstream-service-time
3
server
envoy
content-length
0
/
trc.lhmos.com/uid/save/
Redirect Chain
  • https://trc.lhmos.com/uid/set?dgid=UNK&mcode=15710&mid=47
  • https://ib.adnxs.com/getuidu?https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=$UID
  • https://ib.adnxs.com/bounce?%2Fgetuidu%3Fhttps%3A%2F%2Ftrc.lhmos.com%2Fuid%2Fsave%2F%3Fdgid%3DUNK%26mcode%3D15710%26mid%3D47%26uid%3D%24UID
  • https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=4041086862038597955
0
48 B
Image
General
Full URL
https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=4041086862038597955
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.102.246.198 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:04 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-allow-headers
x-requested-with
x-frame-options
DENY
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
*
access-control-max-age
3600
cache-control
no-cache, no-store, max-age=0, must-revalidate
alt-svc
clear
content-length
0
x-xss-protection
1; mode=block
expires
0

Redirect headers

Pragma
no-cache
Date
Thu, 11 Feb 2021 06:40:05 GMT
X-Proxy-Origin
82.102.19.136; 82.102.19.136; 539.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.172.137:80
AN-X-Request-Uuid
03aac400-0955-4b4d-a47e-ff63a0636f9c
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://trc.lhmos.com/uid/save/?dgid=UNK&mcode=15710&mid=47&uid=4041086862038597955
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
favicon-32x32.png
nextroll.com/
2 KB
2 KB
Image
General
Full URL
https://nextroll.com/favicon-32x32.png
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.175.47.233 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-35-175-47-233.compute-1.amazonaws.com
Software
Apache /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:05 GMT
Via
1.1 vegur
Last-Modified
Wed, 03 Feb 2021 17:24:20 GMT
Server
Apache
Etag
"64f-5ba71db7c9900"
Content-Type
image/png
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1615
script.js
polo.feathr.co/v1/analytics/match/
290 B
579 B
Script
General
Full URL
https://polo.feathr.co/v1/analytics/match/script.js?pk=feathr
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
gzip
server
nginx/1.17.8
etag
W/"6024d144d6e61100084752f1"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, max-age=0
access-control-allow-credentials
true
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
pixel.js
polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/
32 B
397 B
Script
General
Full URL
https://polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/pixel.js?pk=feathr
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/javascript
access-control-allow-origin
*
cache-control
must-revalidate, max-age=14400
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
32
gen_204
pagead2.googlesyndication.com/pagead/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gfp_cw_status&domain=cancertherapyadvisor.com&host=www.cancertherapyadvisor.com&success=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:05 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame B439
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
osd.js
www.googletagservices.com/activeview/js/current/
74 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1612960672666234"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
28344
x-xss-protection
0
expires
Thu, 11 Feb 2021 06:40:05 GMT
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash

Request headers

Referer
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?vt=15.38.9&ver=1.0.58
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.210.166.195 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-210-166-195.compute-1.amazonaws.com
Software
/ Express
Resource Hash

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 6580
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 1293
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
redir
trc.lhmos.com/enrich/data/
2 B
319 B
XHR
General
Full URL
https://trc.lhmos.com/enrich/data/redir?mid=47&mcode=15710&uid=0
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.102.246.198 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
198.246.102.34.bc.googleusercontent.com
Software
/
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:05 GMT
via
1.1 google
x-content-type-options
nosniff
access-control-allow-headers
x-requested-with
x-frame-options
DENY
access-control-allow-methods
POST, GET, OPTIONS, DELETE
content-type
application/json
access-control-allow-origin
*
access-control-max-age
3600
cache-control
no-cache, no-store, max-age=0, must-revalidate
alt-svc
clear
content-length
2
x-xss-protection
1; mode=block
expires
0
match
polo-v1.feathr.co/v1/analytics/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=6024d144d6e61100084752f1&gdpr=0
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=6fgi4r1&ttd_tpi=1&ttd_puid=6024d144d6e61100084752f1&gdpr=0
  • https://polo-v1.feathr.co/v1/analytics/match?f_id=6024d144d6e61100084752f1&ttd_id=964c2c6d-37d9-49e2-bc0c-2de7e6966a94
43 B
402 B
Image
General
Full URL
https://polo-v1.feathr.co/v1/analytics/match?f_id=6024d144d6e61100084752f1&ttd_id=964c2c6d-37d9-49e2-bc0c-2de7e6966a94
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:06 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=0,no-cache,no-store
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
43

Redirect headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:05 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://polo-v1.feathr.co/v1/analytics/match?f_id=6024d144d6e61100084752f1&ttd_id=964c2c6d-37d9-49e2-bc0c-2de7e6966a94
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
267
crumb
polo.feathr.co/v1/analytics/
43 B
402 B
Image
General
Full URL
https://polo.feathr.co/v1/analytics/crumb?cb=1613025605680&a_id=5ac50f6bf60e8103ce30c554&f_id=6024d144d6e61100084752f1&ses_id=6024d14428b9817fd1224246&flvr=page_view&loc_url=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&s_w=1600&s_h=1200&b_w=1600&b_h=1200&cust_params=e30=&utm_params=eyJ1dG1fc291cmNlIjoibmV3c2xldHRlciIsInV0bV9tZWRpdW0iOiJlbWFpbCIsInV0bV9jYW1wYWlnbiI6ImN0YS1wcm9tby1kbWQtMjAyMTAyMTEifQ==
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:05 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
image/gif
access-control-allow-origin
*
cache-control
max-age=0,no-cache,no-store
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
43
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 39EF
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 42B4
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
container.html
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/ Frame 9800
0
0
Document
General
Full URL
https://7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-37/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
content-length
2973
date
Thu, 11 Feb 2021 06:40:04 GMT
expires
Fri, 11 Feb 2022 06:40:04 GMT
last-modified
Thu, 21 Nov 2019 16:01:11 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
2
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-NPWKPG6
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.108.64.33 , Netherlands, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-108-64-33.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date
Thu, 11 Feb 2021 06:40:06 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Sun, 14 Feb 2021 06:40:06 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
485 B
999 B
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:e4::ac40:a517 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:06 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"max_age":604800,"report_to":"cf-nel"}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"group":"cf-nel","endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=7b4Vo0i%2BV4rQr2XKywQI%2FkTrzYtpvEWqEO2SpE%2BHfbl41EIkA%2B23flK1jbEv4s%2Bk2al6h90klnOb9qngWkafLMknuLYnOI1xZeAoVaynkUH%2BtGFd6E4vvw%3D%3D"}],"max_age":604800}
content-type
text/javascript
cache-control
no-cache, no-store, must-revalidate
cf-ray
61fc13971c331762-FRA
cf-request-id
08316a9271000017628d9bf000000001
expires
-1
sodar
pagead2.googlesyndication.com/getconfig/
8 KB
7 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2021020801&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin
*
date
Thu, 11 Feb 2021 06:40:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
6421
x-xss-protection
0
pixel.js
polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/integrations/facebook/
0
319 B
Script
General
Full URL
https://polo.feathr.co/v1/accounts/5ac50f6bf60e8103ce30c554/integrations/facebook/pixel.js
Requested by
Host: cdn.feathr.co
URL: https://cdn.feathr.co/js/boomerang.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.221.108.253 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-221-108-253.compute-1.amazonaws.com
Software
nginx/1.17.8 /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=15724800; includeSubDomains

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:06 GMT
server
nginx/1.17.8
strict-transport-security
max-age=15724800; includeSubDomains
access-control-allow-methods
GET, POST, PUT, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Authorization
content-length
0
collect
www.google-analytics.com/
35 B
63 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j87&a=639314249&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.cancertherapyadvisor.com%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dcta-promo-dmd-20210211%26cpn%3D%26hmSubId%3D%26hmEmail%3D%26NID%3D1023182227%26email_hash%3Dc787cf24de0ee21afa8d5bb76c36e25a%26dl%3D0%26mpweb%3D1323-122433-6789979&ul=en-us&de=UTF-8&dt=Promising%20Efficacy%20Seen%20With%20LOXO-305%20in%20R%2FR%20CLL%2FSLL%20-%20Cancer%20Therapy%20Advisor&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Fconference-coverage%2Famerican-society-of-hematology-ash%2Fash-2020%2Fash-2020-cll-in-depth%2Fchronic-leukemia-cll-loxo-305-promising-efficacy-treatment%2F&el=25%25&ev=25&_u=aGDAAAAjQAAAAC~&jid=&gjid=&cid=1762312596.1613025604&tid=UA-1290429-34&_gid=1808787875.1613025604&gtm=2wg230NPWKPG6&z=426020704
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 10 Feb 2021 18:22:37 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
44249
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
sodar2.js
tpc.googlesyndication.com/sodar/
17 KB
6 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021020801.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:06 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1611170586013198"
vary
Accept-Encoding
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6403
x-xss-protection
0
expires
Thu, 11 Feb 2021 06:40:06 GMT
runner.html
tpc.googlesyndication.com/sodar/sodar2/221/ Frame 7E13
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/221/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/221/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
content-length
4984
date
Thu, 11 Feb 2021 01:28:27 GMT
expires
Fri, 11 Feb 2022 01:28:27 GMT
last-modified
Tue, 08 Dec 2020 21:41:15 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
18699
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
aframe
www.google.com/recaptcha/api2/ Frame 58A6
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82b::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-gKaKboWotR+dJBzUX2FPYg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.google.com
:scheme
https
:path
/recaptcha/api2/aframe
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

expires
Thu, 11 Feb 2021 06:40:06 GMT
date
Thu, 11 Feb 2021 06:40:06 GMT
cache-control
private, max-age=300
content-type
text/html; charset=utf-8
content-security-policy
script-src 'report-sample' 'nonce-gKaKboWotR+dJBzUX2FPYg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-encoding
gzip
x-content-type-options
nosniff
x-xss-protection
1; mode=block
content-length
299
server
GSE
alt-svc
h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
pp.js
api-35-160-123-46.b2c.com/s/
12 KB
5 KB
Script
General
Full URL
https://api-35-160-123-46.b2c.com/s/pp.js
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:e4::ac40:a517 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:06 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 08 Feb 2021 19:37:44 GMT
server
cloudflare
age
1579
etag
W/"60219308-2f5c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"group":"cf-nel","endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=yq%2Fv65L1CCdW%2FaKJD9dGIlCOAdu3CPPY1PXjbVo5fV5i2u3v9C6R%2FLQGbJevQk7Omy0YqsuuJuW7ccPXbQ06waEyg%2B%2F%2BYAZGvTAJNo5I8vCn%2FVO1gadim5PYa7TN9QvxBJtQL7xk"}],"max_age":604800}
content-type
text/javascript
nel
{"max_age":604800,"report_to":"cf-nel"}
cf-ray
61fc13997ebb1762-FRA
cf-request-id
08316a93ef000017627c8ca000000001
ad.gif
api-35-160-123-46.b2c.com/api/
43 B
368 B
Image
General
Full URL
https://api-35-160-123-46.b2c.com/api/ad.gif
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:e4::ac40:a517 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date
Thu, 11 Feb 2021 06:40:06 GMT
cf-cache-status
DYNAMIC
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
nel
{"max_age":604800,"report_to":"cf-nel"}
report-to
{"group":"cf-nel","endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=xolmP%2FFuCBbUsfE6G8tSGKkPbCGIo%2BzJ%2FxfwE9vBDq6uGfy3KBEo1Ru3CP2750kUYrvAS3I6NGM7jIWI1e1HnY%2BXJweR6x1R5MWlWec7HC9Rs9z3tAKL55PZ3v3NqPNSEUOoq4EU"}],"max_age":604800}
content-type
image/gif
cf-ray
61fc139a0f5d1762-FRA
content-length
43
cf-request-id
08316a944500001762c5bb8000000001
gen_204
pagead2.googlesyndication.com/pagead/
0
31 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=221&t=2&li=gpt_2021020801&jk=1978444505611150&bg=!gIOlg8DNAAWP4B5EjzsAKQB2-Dxasdn0zrlqHJlIkvi-Tyx-Z7Va8_AYDTE516oizmIH2I96Fhm2AgAAAGlSAAAAFGgBBwoBULL7GzNF3i3A3k_T5BZjcuTK7QKU8yjekg94wlPChfASzFTwvufOSbXDQjDasd0DXM9xXy0RHPQYZGKUwGItUGF_z_hICGgJN4LiIMTgHGrS7Ld5MzF8uEax2PVCI_sR4seTQZesKXufJfWu76_x9miiXaUjqPlxTS-wRJ200LlI6BkECKePPFUkZGwD9dpw9Pl-vv2UP1wZO4BRkp7x4D1IddEJlFql4lY4rc_i9RB8Rp9k0xhpTRjM88btY_iOVhLGMljfO48VHVgQv5l2-hKZA7r2vfrrUvKN1LAJydR7eopEuNgrS322K2qhMhgrLZCLPL52q5RAqXUZo5yBfpy7NukSWSWwUkRGxNB6nVGpDhdVUGQ53nWrdpzQ1Dt1WkrXlvyb2NReT5ehO089A4-DH559dX-ruq6-_X2QhsP4Zljxk_IIMON2UevIUKVlU5kB3enG-yu1mEJl-uGWsOunJ8sSPzWtF6ficMjC3Nabmh0viJ_tn_6J0tIiMqER4tNzbPXdZxZ6nVfkjR9YGHvNEEZnzbdsH8f_6Z46Z6WfMfs9Nbw1-FB_Zpq1e71JnKZeI7HWZ2LG1mdxt4Y-QWLpscpWIujaGQa-fcNcx569bVWwVu22aJ9tC1BhlmDBzT5Dwggnr9ezGO83eG1ADV3SWrvhsPOxpf99Zj8ddANuUsA9evOuTq3LV6B8Bjrer5JhcUlUJyJhQn4DcaimEmz04rMPhDqQhmvX6OlSmNiG8I4984By2UB1zTmKVBMdYLXu7fZocILzlSU5wxROlZm0ZAd2fqmXSLKWXOLMcqjf6o7iWLGVo4RS8ueON4OSYYBwH1H8l3PcPvwX2BFrDMxCOQy9_hhdqe--BtTBkgyexl0WcdV3rIXahlB3q6t8kBVDh-71FPagu3aoj3K-4B7gegZWVsxTRa1stZb-iYyPu3m3KQ6iABM_-y2h_L9k9_Xi-Hr8Np9VwksTAHHVUpV2DonAuj0hL2syJY8em9JzyQkXbQYFKgdwjRcNhNTNxo99csIqAQmKYHmto6-6ymSs8jGw_8Qaz60GOm4Ie_KIIjrkdxAsjyjz_bargpT0RA
Protocol
H3-Q050
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma
no-cache
date
Thu, 11 Feb 2021 06:40:06 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
4
v4-api-35-160-123-46.b2c.com/api/
Redirect Chain
  • https://api-35-160-123-46.b2c.com/api/x?wg2ISyCZJgsS24mL$dXJsJDAkaHR0cHM6Ly93d3cuY2FuY2VydGhlcmFweWFkdmlzb3IuY29tL2hvbWUvbmV3cy9jb25mZXJlbmNlLWNvdmVyYWdlL2FtZXJpY2FuLXNvY2lldHktb2YtaGVtYXRvbG9neS1h...
  • https://v4-api-35-160-123-46.b2c.com:444/api/4?wg2ISyCZJgsS24mL
43 B
441 B
XHR
General
Full URL
https://v4-api-35-160-123-46.b2c.com:444/api/4?wg2ISyCZJgsS24mL
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.160.123.46 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-160-123-46.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma
no-cache
Date
Thu, 11 Feb 2021 06:40:07 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

date
Thu, 11 Feb 2021 06:40:07 GMT
cf-cache-status
DYNAMIC
nel
{"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
location
https://v4-api-35-160-123-46.b2c.com:444/api/4?wg2ISyCZJgsS24mL
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html
access-control-allow-origin
https://www.cancertherapyadvisor.com
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=3GDSHn5VYYxo364uTMcMCB3RYKDRgCCsw5DtHjqpYKm0u4lY7QSBA455v5aqaqunegYBDKw9xspgRsxRof4OlNnqk9fV%2F4LfmlPjViYPd2bmsq%2BBFg%2FztPaGcJ82EQmoTVHJdzSx"}],"max_age":604800,"group":"cf-nel"}
access-control-allow-credentials
true
cf-ray
61fc139cdb512b65-FRA
cf-request-id
08316a960700002b656d9b9000000001
x
api-35-160-123-46.b2c.com/api/
0
530 B
Other
General
Full URL
https://api-35-160-123-46.b2c.com/api/x?wg2ISyCZJgsS24mL$YWRibG9jayQ1MDkkMA~~
Requested by
Host: api-35-160-123-46.b2c.com
URL: https://api-35-160-123-46.b2c.com/s/pp.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:e4::ac40:a517 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Thu, 11 Feb 2021 06:40:07 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"max_age":604800,"report_to":"cf-nel"}
access-control-allow-methods
GET, POST, OPTIONS
cf-request-id
08316a9695000017624ea70000000001
pragma
no-cache
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"group":"cf-nel","endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report?s=Ye1Q3KVt2ntVwVyzK4mJYqcUq5nO2exyPvBkC84UvBeTytVO8ypVM%2BbHwpu5jimWD30hL8jCJZkHfUprHK1Sb73osshnmkf3sZsKni5uerxIJ4%2FRtJtQxTUBKyEaXaVkDW%2Flk0lk"}],"max_age":604800}
content-type
text/plain; charset=utf-8
access-control-allow-origin
https://www.cancertherapyadvisor.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
61fc139dbb451762-FRA
expires
-1
syncpixel.html
cdn.deepintent.com/ Frame 57C0
0
0
Document
General
Full URL
https://cdn.deepintent.com/syncpixel.html
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.16.136 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
136.16.211.130.bc.googleusercontent.com
Software
UploadServer /
Resource Hash

Request headers

:method
GET
:authority
cdn.deepintent.com
:scheme
https
:path
/syncpixel.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

x-guploader-uploadid
ABg5-Ux043Rjifbx5kBrqqdZqFzVV0_iVZXcWtcFWlfQCuL0SOO50QmHF6UKH0IAbncQanNjDteozVNguMoB6ap9iIk
expires
Thu, 11 Feb 2021 06:42:18 GMT
date
Thu, 11 Feb 2021 05:42:18 GMT
last-modified
Tue, 07 Jan 2020 20:56:29 GMT
etag
"c846b1444882edf729891835b67c4843"
x-goog-generation
1578430589400900
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
x-goog-stored-content-length
1458
content-type
text/html
x-goog-hash
crc32c=O435+Q== md5=yEaxREiC7fcpiRg1tnxIQw==
x-goog-storage-class
STANDARD
accept-ranges
bytes
content-length
1458
access-control-allow-origin
*
server
UploadServer
age
3469
cache-control
public, max-age=3600
alt-svc
clear
syncpixel.html
cdn.deepintent.com/ Frame EA07
0
0
Document
General
Full URL
https://cdn.deepintent.com/syncpixel.html
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.16.136 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
136.16.211.130.bc.googleusercontent.com
Software
UploadServer /
Resource Hash

Request headers

:method
GET
:authority
cdn.deepintent.com
:scheme
https
:path
/syncpixel.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

x-guploader-uploadid
ABg5-Ux043Rjifbx5kBrqqdZqFzVV0_iVZXcWtcFWlfQCuL0SOO50QmHF6UKH0IAbncQanNjDteozVNguMoB6ap9iIk
expires
Thu, 11 Feb 2021 06:42:18 GMT
date
Thu, 11 Feb 2021 05:42:18 GMT
last-modified
Tue, 07 Jan 2020 20:56:29 GMT
etag
"c846b1444882edf729891835b67c4843"
x-goog-generation
1578430589400900
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
x-goog-stored-content-length
1458
content-type
text/html
x-goog-hash
crc32c=O435+Q== md5=yEaxREiC7fcpiRg1tnxIQw==
x-goog-storage-class
STANDARD
accept-ranges
bytes
content-length
1458
access-control-allow-origin
*
server
UploadServer
age
3469
cache-control
public, max-age=3600
alt-svc
clear
syncpixel.html
cdn.deepintent.com/ Frame 606E
0
0
Document
General
Full URL
https://cdn.deepintent.com/syncpixel.html
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.16.136 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
136.16.211.130.bc.googleusercontent.com
Software
UploadServer /
Resource Hash

Request headers

:method
GET
:authority
cdn.deepintent.com
:scheme
https
:path
/syncpixel.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

x-guploader-uploadid
ABg5-Ux043Rjifbx5kBrqqdZqFzVV0_iVZXcWtcFWlfQCuL0SOO50QmHF6UKH0IAbncQanNjDteozVNguMoB6ap9iIk
expires
Thu, 11 Feb 2021 06:42:18 GMT
date
Thu, 11 Feb 2021 05:42:18 GMT
last-modified
Tue, 07 Jan 2020 20:56:29 GMT
etag
"c846b1444882edf729891835b67c4843"
x-goog-generation
1578430589400900
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
x-goog-stored-content-length
1458
content-type
text/html
x-goog-hash
crc32c=O435+Q== md5=yEaxREiC7fcpiRg1tnxIQw==
x-goog-storage-class
STANDARD
accept-ranges
bytes
content-length
1458
access-control-allow-origin
*
server
UploadServer
age
3469
cache-control
public, max-age=3600
alt-svc
clear
syncpixel.html
cdn.deepintent.com/ Frame EB5D
0
0
Document
General
Full URL
https://cdn.deepintent.com/syncpixel.html
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.16.136 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
136.16.211.130.bc.googleusercontent.com
Software
UploadServer /
Resource Hash

Request headers

:method
GET
:authority
cdn.deepintent.com
:scheme
https
:path
/syncpixel.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

x-guploader-uploadid
ABg5-Ux043Rjifbx5kBrqqdZqFzVV0_iVZXcWtcFWlfQCuL0SOO50QmHF6UKH0IAbncQanNjDteozVNguMoB6ap9iIk
expires
Thu, 11 Feb 2021 06:42:18 GMT
date
Thu, 11 Feb 2021 05:42:18 GMT
last-modified
Tue, 07 Jan 2020 20:56:29 GMT
etag
"c846b1444882edf729891835b67c4843"
x-goog-generation
1578430589400900
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
x-goog-stored-content-length
1458
content-type
text/html
x-goog-hash
crc32c=O435+Q== md5=yEaxREiC7fcpiRg1tnxIQw==
x-goog-storage-class
STANDARD
accept-ranges
bytes
content-length
1458
access-control-allow-origin
*
server
UploadServer
age
3469
cache-control
public, max-age=3600
alt-svc
clear
syncpixel.html
cdn.deepintent.com/ Frame 6EDF
0
0
Document
General
Full URL
https://cdn.deepintent.com/syncpixel.html
Requested by
Host: www.cancertherapyadvisor.com
URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-header-bidding-dfpapi/js/prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
130.211.16.136 Mountain View, United States, ASN15169 (GOOGLE, US),
Reverse DNS
136.16.211.130.bc.googleusercontent.com
Software
UploadServer /
Resource Hash

Request headers

:method
GET
:authority
cdn.deepintent.com
:scheme
https
:path
/syncpixel.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
accept-encoding
gzip, deflate, br
accept-language
en-US
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979

Response headers

x-guploader-uploadid
ABg5-Ux043Rjifbx5kBrqqdZqFzVV0_iVZXcWtcFWlfQCuL0SOO50QmHF6UKH0IAbncQanNjDteozVNguMoB6ap9iIk
expires
Thu, 11 Feb 2021 06:42:18 GMT
date
Thu, 11 Feb 2021 05:42:18 GMT
last-modified
Tue, 07 Jan 2020 20:56:29 GMT
etag
"c846b1444882edf729891835b67c4843"
x-goog-generation
1578430589400900
x-goog-metageneration
1
x-goog-stored-content-encoding
identity
x-goog-stored-content-length
1458
content-type
text/html
x-goog-hash
crc32c=O435+Q== md5=yEaxREiC7fcpiRg1tnxIQw==
x-goog-storage-class
STANDARD
accept-ranges
bytes
content-length
1458
access-control-allow-origin
*
server
UploadServer
age
3469
cache-control
public, max-age=3600
alt-svc
clear
entry2
monitor.clickcease.com/V2/recorder/ Frame
0
0
Other
General
Full URL
https://monitor.clickcease.com/V2/recorder/entry2
Protocol
H2
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Kestrel /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.cancertherapyadvisor.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

server
Kestrel
access-control-allow-headers
content-type
access-control-allow-methods
POST
access-control-allow-origin
*
vm
10.1.0.24
date
Thu, 11 Feb 2021 06:40:07 GMT
entry2
monitor.clickcease.com/V2/recorder/
29 B
86 B
Fetch
General
Full URL
https://monitor.clickcease.com/V2/recorder/entry2
Requested by
Host: www.clickcease.com
URL: https://www.clickcease.com/monitor/stat.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a01:111:f100:2000::a83e:3309 Washington, United States, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Kestrel /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=2592000

Request headers

Referer
https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2020/ash-2020-cll-in-depth/chronic-leukemia-cll-loxo-305-promising-efficacy-treatment/?utm_source=newsletter&utm_medium=email&utm_campaign=cta-promo-dmd-20210211&cpn=&hmSubId=&hmEmail=&NID=1023182227&email_hash=c787cf24de0ee21afa8d5bb76c36e25a&dl=0&mpweb=1323-122433-6789979
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type
application/json

Response headers

access-control-allow-origin
*
strict-transport-security
max-age=2592000
server
Kestrel
vm
10.1.0.24
date
Thu, 11 Feb 2021 06:40:08 GMT
content-type
text/plain; charset=utf-8

Verdicts & Comments Add Verdict or Comment

0 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

0 Cookies

11 Console Messages

Source Level URL
Text
console-api info URL: webpack:///./node_modules/react-dom/cjs/react-dom.development.js?(Line 24994)
Message:
%cDownload the React DevTools for a better development experience: https://fb.me/react-devtools font-weight:bold
console-api log URL: webpack:///./src/js/hm-bibblio-recommended-module.js?(Line 11)
Message:
99088
console-api log URL: webpack:///./src/js/hm-bibblio-recommended-module.js?(Line 46)
Message:
[object Object]
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/plugins/hm-throtle-manager/js/hm-throtle-manager.js?ver=1.0.1(Line 3)
Message:
[object Object]
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api error URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12(Line 12)
Message:
An Error Occurred in the callback in AIM.ondetect(): TypeError: Cannot read property 'EventBus' of undefined
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1608135108(Line 1)
Message:
[ABD] exiting test loop - value: false

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Frame-Options SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

7b9c0d35c76d20b9b3f2a550aad9bab7.safeframe.googlesyndication.com
accounts.haymarketmedia.com
adservice.google.be
adservice.google.com
api-35-160-123-46.b2c.com
api.b2c.com
api.bibblio.org
cdn.bibblio.org
cdn.cookielaw.org
cdn.deepintent.com
cdn.feathr.co
content.maropost.com
content.tapnative.com
d.adroll.com
d.adroll.mgr.consensu.org
fonts.googleapis.com
fonts.gstatic.com
geolocation.onetrust.com
ib.adnxs.com
link.email.empr.com
marco.feathr.co
match.adsrvr.org
match.deepintent.com
monitor.clickcease.com
mpct1.maropost.com
nextroll.com
pagead2.googlesyndication.com
polo-v1.feathr.co
polo.feathr.co
prebid.deepintent.com
s.adroll.com
s3.amazonaws.com
sb.scorecardresearch.com
securepubads.g.doubleclick.net
stats.g.doubleclick.net
subapi.haymarketmedia.com
thrtle.com
tpc.googlesyndication.com
trc.lhmos.com
v4-api-35-160-123-46.b2c.com
www.cancertherapyadvisor.com
www.clickcease.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
100.26.59.51
104.108.64.33
13.224.196.58
130.211.16.136
142.250.185.130
23.218.208.121
2600:9000:206f:cc00:a:1779:3180:93a1
2606:4700:10::6814:b844
2606:4700:20::ac43:4470
2606:4700:3031::ac43:80a4
2606:4700::6810:9540
2606:4700:e4::ac40:a417
2606:4700:e4::ac40:a517
2a00:1450:4001:800::2008
2a00:1450:4001:808::2002
2a00:1450:4001:80f::200a
2a00:1450:4001:810::2003
2a00:1450:4001:811::2001
2a00:1450:4001:812::2001
2a00:1450:4001:812::200e
2a00:1450:4001:828::2002
2a00:1450:4001:828::2004
2a00:1450:4001:829::2003
2a00:1450:4001:82b::2004
2a00:1450:400c:c04::9a
2a01:111:f100:2000::a83e:3309
3.211.216.130
3.221.108.253
3.233.21.95
34.102.246.198
34.193.226.227
35.160.123.46
35.175.47.233
35.238.129.105
37.252.173.27
52.216.176.149
52.5.164.199
52.86.201.23
54.209.3.159
54.210.166.195
54.74.225.211
54.74.23.153
65.9.69.116
65.9.69.72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